Early Growth and Adult Health : Focus on Resting Metabolism, Non-alcoholic Fatty Liver Disease, Hypertension and Regional Differences in Birth Size by Sandboge, Samuel
  
 
Early Growth and Adult Health 
 
Focus on Resting Metabolism, Non-alcoholic Fatty Liver Disease, Hypertension 
and Regional Differences in Birth Size 
 
 
Samuel Sandboge 
 
Folkhälsan Research Centre 
and 
National Institute for Health and Welfare, 
Department of Chronic Disease Prevention 
 
Faculty of Medicine 
University of Helsinki 
Finland  
 
ACADEMIC DISSERTATION 
 
 
To be publicly discussed, with the permission of the Faculty of Medicine of the  
University of Helsinki, in Auditory XII, University Main Building, 
 Unioninkatu 34, Helsinki on August 21st 2015 at 12 noon. 
 
 
Helsinki 2015 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cover illustration: Bettina Sandboge 
 
Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis 
Helsinkiensis  
 
No 53/2015    http://ethesis.helsinki.fi 
 
ISBN 978-951-51-1384-9 (paperback)  ISSN 2342-3161 (print) 
ISBN 978-951-51-1385-6 (PDF)  ISSN 2342-317X (online) 
 
Cover layout: Anita Tienhaara 
 
Hansaprint 
Vantaa, 2015  
 
 
 
 
 
Supervised by 
 
Professor Johan Eriksson, MD, DMSc 
Clinicum, Department of General Practice and Primary Health Care, 
University of Helsinki 
Helsinki, Finland 
 
and 
 
Folkhälsan Research Centre 
 
and 
 
Department of Chronic Disease Prevention, 
National Institute for Health and Welfare 
 
 
Reviewed by 
 
Adjunct Professor Harri Niinikoski, MD, DMSc 
Department of Pediatrics 
Turku University Hospital 
Turku, Finland 
 
and 
 
Professor Leo Niskanen, MD, DMSc 
School of Medicine, Faculty of Health Sciences,  
University of Eastern Finland 
Kuopio, Finland 
 
 
Opponent 
 
Professor Tom Pettersson, MD, DMSc 
Clinicum, Department of Medicine 
University of Helsinki 
Helsinki, Finland 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my family  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The true delight is in the finding out, rather than in the knowing. 
 
- Isaac Asimov 
 
 
 
 
  
! 7!
Abstract 
 
Background. According to the Developmental Origins of Health and Disease 
(DOHaD) hypothesis, several non-communicable diseases (NCDs) have their origin in 
utero and during early childhood. The developing fetus responds to environmental 
cues including maternal nutritional and hormonal status, placental function and 
potential environmental toxins. This in turn affects organ development and growth, 
and the setting of hormonal axes, a process called programming. A suboptimal 
intrauterine environment often leads to a small body size at birth which is associated 
with the prevalence of several NCDs. These associations are in many cases further 
affected by childhood growth trajectories. NCD prevalence often varies according to 
region and potentially, this regional variation could partly have its origin in early 
development. Current lifestyle factors further influence NCD prevalence.  
 
Aims. The main aim of this thesis was to explore the associations between early growth 
and outcomes directly or indirectly related to features of the metabolic syndrome, 
specifically hypertension, NAFLD, body composition, and resting metabolism. We 
also aimed to assess the association between fructose intake and NAFLD, and regional 
differences in birth size between Helsinki and the Åland Islands.  
 
Subjects and methods. The Helsinki Birth Cohort Study consists of 13345 men and 
women born in Helsinki in 1934‒44. A detailed set of records are available for the 
participants, including information on maternal and birth characteristics, childhood 
socioeconomic status, and serial measurements of childhood body size. In all, 2003 
individuals participated in a clinical study in 2001‒04 and 1083 of these additionally 
participated in a follow-up study in 2006‒08. The clinical examinations included 
laboratory samples and measurement of body composition, resting metabolism and 
blood pressure. Information on dietary and lifestyle habits were collected using 
questionnaires. The Åland records included 1697 births for the years 1937‒44. 
 
Results. Birth weight was inversely associated with resting metabolic rate after 
adjustment for age, gestational age, and fat-free mass in women. In men, the 
association was quadratic (u-shaped), with and without additional adjustment for fat 
mass. A more rapid than expected conditional relative weight gain after age 11 years, 
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i.e. a higher attained adult weight than would have been expected based on adult height 
as well as weight and height measurements before age 11 years, was strongly 
associated with increase in adult fat mass and body fat percentage. These increased 8.6 
kg (95% CI 8.4; 8.7) and 5.5% (95% CI 5.3; 5.7) per SD of the adult conditional 
relative weight variable, respectively.  
 
The prevalence of NAFLD, defined by the NAFLD liver fat score algorithm test, was 
inversely associated with several measurements of childhood body size and growth. 
Conversely, individuals who belonged to the lowest tertile of BMI at age 2 years and 
subsequently were obese as adults, had an odds ratio (OR) of 18.5 (95% CI 10.1; 33.6) 
for NAFLD compared to those who were still lean or normal weight in adulthood.  
 
The prevalence of NAFLD, defined by the fatty liver index (FLI) algorithm test, was 
inversely associated with fructose intake, independent of lifestyle and dietary factors, 
sex, and age. The OR for NAFLD in the quartile with the highest fructose intake was 
0.68 (95% CI 0.47; 0.97) in the fully adjusted model compared to the quartile with the 
lowest intake. 
 
Systolic blood pressure (SBP) and the presence of hypertension at mean age 66.4 years 
was inversely associated with linear (height) growth between ages 2 and 11 years. SBP 
was additionally inversely associated with relative weight gain in the same age range. 
Conversely, relative weight gain after age 11 years was positively associated with SBP 
at mean ages 61.5 years and 66.4 years. 
 
Mean birth weight on the Åland Islands in the years 1937‒44 was 3499 grams, 87 
grams (95% CI 61; 111) more than in Helsinki during the same years. Ålandic babies 
were also 0.4 cm (95% CI 0.3; 0.5) longer than their Helsinki peers. 
 
Conclusions. A more pronounced increase in body size than would be expected from 
previous body size after age 11 years was positively associated with increased body fat 
percentage and the presence of NAFLD at mean age 61.5 years and additionally with 
hypertension at mean age 66.4 years. While rapid growth during childhood in this 
cohort of Finnish men and women born 1934‒44 most likely represents the influence 
of a beneficial postnatal environment, relative weight gain after age 11 years is 
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associated with increase in fat mass and the beginning of obesity and related 
conditions. Contrary to previous findings, we found that individuals with the highest 
intake of fructose were least likely to suffer from NAFLD. This inconsistency is most 
likely due to the fact that fructose intake in our cohort was relatively low and primarily 
from fruits rather than from soft drinks. We found a small but significant difference in 
body size at birth between the Åland Islands and Helsinki for the years 1937‒44. 
Although insufficient to explain the differences in health and longevity between Åland 
and the rest of Finland, the findings indicate that regional health differences potentially 
were present during the period, meriting further studies of Ålandic health from a life-
course perspective. 
 
Keywords: basal metabolism, birth length, birth weight, blood pressure, body 
composition, fetal programming, fructose, hypertension, metabolic syndrome, non-
alcoholic fatty liver disease, regional health differences. 
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Sammanfattning 
 
Bakgrund. DOHaD-hypotesen (Developmental Origins of Health and Disease) föreslår 
att ett flertal folksjukdomar har sina ursprung under fosterlivet och tidig barndom. Det 
växande fostret exponeras för signaler från omgivningen, till exempel kopplade till 
moderkakans funktion, moderns hormonella status och näringsnivåer samt yttre 
miljöfaktorer. Dessa signaler påverkar fostrets utveckling och tillväxt samt de 
hormonella axlarnas funktion i en process som kallas programmering. En ogynnsam 
fostermiljö leder ofta till en liten födelsestorlek vilket i sin tur är kopplat till en ökad 
risk för ett flertal folksjukdomar. Dessa samband påverkas ofta ytterligare av 
tillväxtmönster under barndomen. Vidare finns i flertalet fall en regional variation i 
folksjukdomars prevalens. Denna variation skulle potentiellt delvis kunna ha sitt 
ursprung under tidig utveckling. Folksjukdomarnas förekomst påverkas också av 
livsstilsfaktorer.  
 
Syften. Avhandlingens huvudsyfte var att studera sambanden mellan tidig tillväxt samt 
tillstånd direkt eller indirekt kopplade till det metabola syndromet, i första hand 
hypertoni, NAFLD (non-alcholic fatty liver disease), kroppsammansättning samt 
viloämnesomsättning. Vi avsåg vidare att studera sambanden mellan intag av fruktos 
och NAFLD samt regionala skillnader i födelsestorlek mellan Helsingfors och Åland. 
 
Deltagare och metoder. Helsingfors födelsekohortstudie består av 13345 män och 
kvinnor födda i Helsingfors 1934‒44. Omfattande uppgifter finns tillgängliga för alla 
deltagare avseende bland annat moderns och födelsens karaktäristika, barndomens 
socioekonomiska förhållanden samt upprepade mätningar av kroppsstorlek under 
barndomen. Sammanlagt 2003 individer deltog i en klinisk studie 2001‒04 varav 1083 
dessutom deltog i en uppföljningsstudie 2006‒08. I de kliniska undersökningarna 
ingick blodprov samt mätning av kroppssammansättning, viloämnesomsättning och 
blodtryck. Frågeformulär användes för att samla in uppgifter om livsstilsvanor samt 
kost. Det åländska materialet innehöll 1697 födslar från åren 1937‒44. 
 
Resultat. Födelsevikt var negativt associerat till vilometabolism efter justering för 
ålder, gestationslängd samt fettfri kroppsmassa bland kvinnor. Bland män var 
association kvadratisk (u-formad), både före och efter ytterligare justering för mängd 
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kroppsfett. En snabbare relativ viktökning än förväntat efter 11 års ålder, det vill säga 
en högre uppnådd vuxen vikt än vad som skulle förväntats utifrån vuxen längd samt 
vikt- och längdmått innan 11 års ålder, var starkt positivt associerat till mängden 
kroppsfett samt fettprocent i vuxen ålder. Dessa ökade 8,6 kg (95% CI 8,4; 8,7) 
respektive 5,5% (95% konfidensintervall 5,3; 5,7) per standardavvikelse av tillväxt-
variabeln.  
 
Förekomsten av NAFLD, definierat medelst algoritmtest (NAFLD liver fat score), var 
negativt associerad med ett flertal kroppsstorleksmått i barndomen. Däremot hade 
personer som tillhörde kohortens lägsta tredjedel av BMI som 2 åringar men därefter 
var obesa som vuxna, en oddskvot på 18,5 (95% konfidensintervall 10,1; 33,6) för 
NAFLD jämfört med de individer som också var smala eller normalviktiga som vuxna. 
 
Förekomsten av NAFLD, definierat medelst algoritmtest (Fatty Liver Index), var 
negativt associerat med fruktosintag, oberoende av kost- och livsstilsfaktorer, kön och 
ålder. Oddskvoten för NAFLD i kvartilen med högst fruktosintag var 0,68 (95% 
konfidensintervall 0,47; 0,97) i den fullt justerade modellen jämfört med kvartilen med 
lägst intag.  
 
Systoliskt blodtryck (SBT) och förekomst av hypertoni vid genomsnittlig ålder 66,4 år 
var negativt associerat till linjär tillväxt (längdtillväxt) mellan 2 och 11 års ålder. SBT 
var dessutom negativt associerat till relativ viktökning under samma åldersintervall. 
Däremot var relativ viktökning efter 11 års ålder positivt associerat till SBT vid både 
61,5 och 66,4 års genomsnittlig ålder. 
 
Genomsnittlig födelsevikt på Åland under åren 1937‒44 var 3499 gram, 87 gram (95% 
konfidensintervall 61; 111) mer än i Helsingfors under samma år. Åländska nyfödda 
var dessutom 0,4 cm (95% konfidensintervall 0,3; 0,5) längre än de som föddes i 
Helsingfors. 
 
Slutsatser. En mer påtaglig ökning av kroppsstorlek, än vad som kunnat förutses från 
tidigare kroppsstorlek, efter 11 års ålder var positivt associerat till ökning av procent 
kroppsfett samt förekomst av NAFLD vid genomsnittsålder 61,5 år och dessutom med 
hypertoni vid genomsnittsålder 66,4 år. Emedan snabb tidig tillväxt i denna kohort 
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finländska män och kvinnor födda 1934‒44 i första hand sannolikt är ett tecken på en 
fördelaktig uppväxtmiljö så verkar relativ viktökning efter 11 års ålder vara kopplat till 
ökad mängd kroppsfett samt vara början till fetma och fetmarelaterade tillstånd. I 
motsats till tidigare studiers fynd noterade vi att de individer som konsumerade mest 
fruktos hade lägst förekomst av NAFLD. Denna inkoherens härrör sig sannolikt från 
att fruktosintaget i vår studie var relativt lågt samt i första hand kom från frukt snarare 
än läskedrycker. Vi fann vidare en liten men signifikant skillnad i födelsestorlek 
mellan Åland och Helsingfors under åren 1937‒44. Även om detta inte räcker för att 
förklara skillnaderna i hälsa och medellivslängd mellan Åland och resten av Finland 
antyder våra resultat att regionala hälsoskillnader förekom också under denna period 
vilket torde motivera ytterligare studier av åländsk hälsa ur ett livstidsperspektiv.  
 
Nyckelord: basal ämnesomsättning, blodtryck, fosterutveckling, fruktos, födelselängd, 
födelsevikt, icke alkoholbetingad fettlever, kroppssammansättning, metabola 
syndromet, regionala hälsoskillnader. 
 
 
 
 
 
  
! 13!
Tiivistelmä 
 
Tausta. DOHaD-hypoteesin (Developmental Origins of Health and Disease) mukaan 
useat kansantaudit saavat alkunsa sikiöaikana tai varhaisessa lapsuudessa. Kehittyvä 
sikiö mukautuu ympäristönsä signaaleihin, joihin kuuluvat esimerkiksi äidin 
ravitsemus- ja hormonaalinen tila, istukan toiminta sekä mahdolliset ympäristömyrkyt. 
Nämä vuorostaan vaikuttavat elinten kehitykseen ja kasvuun sekä hormonaalisten 
akseleiden toimintaan eli ilmiöön, jota kutsutaan ohjelmoinniksi. Epäsuotuisa 
kohdunsisäinen ympäristö johtaa usein pieneen syntymäpainoon, mikä itsessään on 
yhteydessä monen kansantaudin esiintyvyyteen. Näihin yhteyksiin vaikuttaa monissa 
tapauksissa vielä lisäksi lapsuuden aikainen kasvu. Kansantautien esiintyvyydessä on 
usein paikallista vaihtelevuutta, ja on mahdollista, että näiden erojen alkuperä on 
sikiöaikaisessa kehityksessä. Elämäntavat ovat myös yhteydessä kansantautien 
esiintyvyyteen. 
 
Tavoitteet. Tämän väitöskirjan tarkoituksena oli tutkia suoria ja epäsuoria yhteyksiä 
varhaisen kasvun ja metabolisen oireyhtymän välillä, ja keskittyä erityisesti 
verenpaineeseen, NAFLD:iin (non-alcoholic fatty liver disease), kehonkoostumukseen 
ja lepoaineenvaihduntaan. Tavoitteena oli myös arvioida yhteyttä nautitun fruktoosi-
määrän ja NAFLD:in välillä sekä lisäksi arvioida eroavaisuuksia syntymäkoossa 
Helsingin ja Ahvenanmaan välillä. 
 
Aineisto ja menetelmät. Epidemiologisena kohorttina oli Helsingin Syntymäkohortti, 
joka koostuu 13345 Helsingissä vuosien 1934‒44 välillä syntyneestä miehestä ja 
naisesta. Heistä on saatavilla yksityiskohtaiset tiedot, mukaan lukien äitiin ja lapsen 
syntymään liittyvät tiedot, perheen sosioekonominen asema ja jatkuva sarja lapsuuden 
kasvuun liittyviä mittauksia. Yhteensä 2003 henkilöä osallistui vuosien 2001‒04 
välillä kliiniseen tutkimukseen ja 1083 heistä osallistui vielä toisen kerran 
seurantatutkimukseen vuosien 2006‒08 välillä. Kliinisiin tutkimuksiin sisältyivät 
verinäytteet sekä kehonkoostumuksen, lepoaineenvaihdunnan ja verenpaineen 
mittaukset. Ruokavalioon ja elintapaan liittyvät tiedot kerättiin kyselylomakkeilla. 
Ahvenanmaan aineistoon kuuluu 1697 syntymää vuosilta 1937–44. 
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Tulokset. Syntymäpaino oli naisilla käänteisesti yhteydessä lepoaineenvaihduntaan sen 
jälkeen kun se oli korjattu iän, gestaatioiän ja rasvattoman painon suhteen. Miehillä 
syntymäpainolla oli kvadraattinen (u-muotoinen) yhteys lepoaineenvaihduntaan, sekä 
vakioituna että ilman vakiointia rasvamassan suhteen. Odotettua nopeampi 
suhteellinen painonnousu 11. ikävuoden jälkeen, eli aikuisikään mennessä saavutettu 
paino on korkeampi kuin mitä voidaan odottaa huomioiden pituus aikuisiällä sekä 
paino- ja pituusmitat ennen 11 vuoden ikää, oli vahvasti yhteydessä lisääntyneeseen 
aikuisiän rasvamassaan ja kehon rasvaprosenttiin, eli 8,6 kg (95 % luottamusväli 8,4; 
8,7) ja 5.5 % (95 % luottamusväli 5,3; 5,7) jokaista vastaavan muuttujan keskihajontaa 
(SD) kohden. 
 
NAFLD:in esiintyvyys, NAFLD määritettynä maksan rasvoittumisasteen lasku-
algoritmilla, oli käänteisesti yhteydessä useaan lapsuusiän kehonkoon ja kasvun 
mittariin. Henkilöillä, jotka kuuluivat BMI:n alimpaan kolmannekseen kahden vuoden 
iässä mutta olivat aikuisina ylipainoisia, oli 18,5-kertainen tautipaine (odds ratio (OR); 
95 % luottamusväli 10,1; 33,6) saada NAFLD verrattuna henkilöihin, jotka olivat 
hoikkia tai normaalipainoisia aikuisiässä. 
 
NAFLD:in esiintyvyys, määritettynä FLI (fatty liver index) laskualgoritmilla, oli 
käänteisesti yhteydessä nautittuun fruktoosimäärään riippumatta elintavoista, 
ruokavaliosta, sukupuolesta ja iästä. Vakioidussa mallissa korkeimman fruktoosin 
käytön neljänneksessä oli 0,68-kertainen tautipaine (OR; 95 % luottamusväli 0,47; 
0,97) saada NAFLD verrattuna neljännekseen, jossa fruktoosin käyttö oli alhaisinta. 
 
Systolinen verenpaine (SVP) ja verenpainetauti keskimäärin 66,4 vuoden iässä olivat 
käänteisesti yhteydessä lineaariseen pituuskasvuun 2. ja 11. ikävuosien välillä. SVP oli 
lisäksi käänteisesti yhteydessä suhteelliseen painonnousuun samassa iässä. 
Suhteellinen painonnousu 11. ikävuoden jälkeen oli sen sijaan suorassa yhteydessä 
SVP:hen 61,5 ja 66,4 vuoden iässä. 
 
Keskimääräinen syntymäpaino oli Ahvenanmaalla vuosien 1937‒44 välillä 3499 
grammaa, eli 87 grammaa (95 % luottamusväli 61;111) suurempi kuin Helsingissä 
samoina vuosina. Ahvenanmaalaiset vauvat olivat 0,4 cm (95 % luottamusväli 0,3; 
0,5) pidempiä kuin Helsingissä. 
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Päätelmät. Aikaisempaan kokoon nähden odotettua nopeampi kasvu 11. ikävuoden 
jälkeen oli suorassa yhteydessä lisääntyneeseen kehon rasvaprosenttiin ja 
sairastumiseen NAFLD:iin keskimäärin 61,5 vuoden iässä ja verenpainetautiin 
keskimäärin 66,4 vuoden iässä. Lapsuuden nopea kasvu vuosina 1934‒44 syntyneillä 
suomalaisilla miehillä ja naisilla mitä todennäköisemmin johtuu suotuisasta 
syntymänjälkeisestä ympäristöstä. Suhteellinen painonnousu 11. ikävuoden jälkeen on 
yhteydessä lisääntyneeseen rasvamassaan ja ylipainon kehittymiseen sekä näihin 
liittyviin sairauksiin. Päinvastoin kuin aikaisemmista tutkimustuloksista on päätelty, 
tässä tutkimuksessa totesimme, että yksilöillä, jotka olivat käyttäneet eniten fruktoosia, 
oli pienin riski sairastua NAFLD:in. Tämä aiempiin tutkimustuloksiin nähden 
poikkeava tulos johtuu mitä todennäköisimmin siitä, että fruktoosin käyttömäärä tässä 
kohortissa oli suhteellisen vähäinen ja se oli ensisijaisesti saatu hedelmistä eikä 
virvoitusjuomista. Lisäksi vuosina 1937‒44 syntyneiden ahvenanmaalaisten ja 
helsinkiläisten vauvojen välillä löytyi pieni mutta merkityksellinen ero syntymä-
painossa ja -pituudessa. Vaikka näillä löydöksillä ei voida selittää eroja terveydessä ja 
eliniässä Ahvenanmaan ja muun Suomen välillä, löydökset viittaavat siihen, että 
paikallisia terveyseroja on ollut mahdollisesti olemassa jo ennen syntymää, mikä luo 
pohjaa ahvenanmaalaisten terveyteen liittyviin lisätutkimuksiin elämänkaari-
näkökulmasta. 
 
Avainsanat: aineenvaihdunta, syntymäpituus, syntymäpaino, verenpaine, 
kehonkoostumus, sikiökauden ohjelmointi, fruktoosi, verenpainetauti, metabolinen 
oireyhtymä, alkoholin käytöstä riippumaton rasvamaksa, paikalliset terveyserot. 
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1 INTRODUCTION 
 
The Developmental Origins of Health and Disease (DOHaD) hypothesis posits that 
environmental exposures during sensitive periods of development can result in 
phenotypic alterations affecting later health and disease susceptibility (Gluckman and 
Hanson, 2006b). Fetal growth, cell and organ development and the setting of 
metabolism and endocrine function are influenced by the intrauterine environment via 
several mechanisms, among them placental function, the mother’s hormonal, 
nutritional and metabolic status, and epigenetic signalling (Fowden et al., 2006). This 
phenomenon is called developmental programming. Traditionally, most studies within 
this field focused upon the long term consequences of being born small. A low birth 
weight, an indicator of a suboptimal intrauterine environment, is associated with an 
increased risk of several common non-communicable diseases (NCDs) in later life. 
This risk is however, in many cases, largely modified by childhood growth patterns.  
  
Growth can be defined in several ways, e.g. through conditional growth modelling, 
which measures how a particular measurement of body size at one point in time relates 
to what would have been expected from previous measurements. Childhood growth 
predicts adult body composition which could be one mediating factor explaining the 
association between developmental programming and adult disease (Singhal et al., 
2003). Lean body mass, mostly composed of muscle mass, is strongly associated with 
resting metabolism which could potentially also be programmed during early 
development. 
 
The metabolic syndrome is a cluster of conditions related to an increased risk of 
developing cardiovascular disease and type 2 diabetes (Alberti et al., 2006). According 
to the Joint International Statement diagnosis criteria from 2009, the syndrome is 
present if three of the following conditions are present: central obesity, raised 
triglycerides, reduced HDL-cholesterol, raised blood pressure and raised fasting 
glucose (Alberti et al., 2009). Non-alcoholic fatty liver disease (NAFLD), 
characterized by a liver fat content above 5‒10% in absence of excessive alcohol 
intake or other liver pathology, has been suggested as the hepatic manifestation of the 
metabolic syndrome (Marchesini et al., 2001). The developmental origins of 
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hypertension have been studied extensively and there is strong experimental and 
epidemiological evidence for the inverse association between body size at birth and 
adult blood pressure. Fewer studies have explored the early origins of NAFLD but due 
to its close association with the metabolic syndrome and type 2 diabetes, a common 
developmental background is likely. Besides traditional risk factors, fructose intake 
has been suggested as a potential risk factor for NAFLD but findings have been 
conflicting.  
 
There are regional variations in the prevalence of several NCDs, in part explained by 
geographic, socioeconomic, and genetic factors. In Finland, people living on the Åland 
Islands are healthier and live longer than their mainland peers. Mean life expectancy 
on the islands has been greater than on the mainland from the second quarter of the 
nineteenth century and at least until the beginning of the twentieth. Few studies have 
explored the background of Ålandic health and longevity. 
 
The works included in this thesis explore a number of aspects of the DOHaD 
hypothesis and are part of the Helsinki Birth Cohort Study (HBCS) which includes 
13345 individuals born in Helsinki 1934‒44. A detailed data set, including birth and 
childhood growth measurements, is available for all individuals, based on birth, 
childhood welfare, and school records. Data from Åland Islands birth records for the 
years 1937‒44 were also analysed in the study of regional differences in birth size. In 
addition to the studies based on the DOHaD hypothesis, the cross-sectional 
associations between NAFLD, assessed by algorithm scores, and fructose intake, were 
also focused upon.  
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2 REVIEW OF THE LITERATURE 
 
2.1 Developmental origins of health and disease 
 
Some of the first human studies suggesting an association between the intrauterine 
environment, early life, and later health outcomes were published almost forty years 
ago. Ravelli and colleagues reported higher rates of obesity in nineteen-year-old men 
who were exposed to the Dutch famine of 1944‒45 in utero during the first half of the 
pregnancy, whereas those who were exposed during the last trimester or during the 
first months of life had lower obesity rates (Ravelli et al., 1976). In 1977, Forsdahl 
demonstrated a positive association between infant mortality and death from 
cardiovascular disease in a study of mortality data from Norway’s 20 counties, 
suggesting that poverty in early life, followed by prosperity, increases the risk of 
cardiovascular disease (Forsdahl, 1977). In fact, Forsdahl suggested an association 
between poor childhood living conditions and high adult mortality rates in an even 
earlier publication in the Journal of the Norwegian Medical Association (Forsdahl, 
1973).  
 
A decade after the publications by Ravelli and Forsdahl, the research of David Barker 
and colleagues expanded upon the theory that early life events could influence later 
health and disease risk. In a 1986 study on variations in mortality data in England and 
Wales, a strong positive geographical association was found between infant mortality 
during the years 1921‒25 and ischaemic heart disease mortality 1968‒78, suggesting 
an increased disease susceptibility related to adult affluent diet, following poor early 
life nutrition (Barker and Osmond, 1986). To explore this hypothesis, Barker and 
colleagues traced a cohort of 5654 men born in Hertfordshire, England, during the 
years 1911‒30. The study demonstrated that those who weighed the least at birth and 
at age one year had the highest ischaemic heart disease mortality (Barker et al., 
1989b). These and subsequent findings gave rise to the Fetal Origins Hypothesis, also 
known as the Barker hypothesis, proposing that cardiovascular disease and related 
conditions are programmed in utero following lasting changes to e.g. developing 
organs, metabolic activity, and hormonal secretion due to fetal malnutrition (Barker, 
1995). The Fetal Origins hypothesis has since been expanded into the DOHaD 
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hypothesis, placing emphasis not only on the prenatal period but on the entire plastic 
phase of development including infancy and early childhood. One of the central 
concepts in the DOHaD hypothesis is that of mismatch. Mismatch occurs when 
phenotypic changes caused by environmental cues in early development do not reflect 
the later environment, for example if fetal undernutrition is followed by childhood 
overnutrition (Gluckman et al., 2008). The mismatch phenomenon is especially 
relevant in societies undergoing rapid socioeconomic transitions.   
 
The original findings of Barker and colleagues on the early life origins of coronary 
heart disease (CHD) have since been reproduced and expanded upon in a large number 
of studies in several different populations (Stein et al., 1996, Leon et al., 1998, Rich-
Edwards et al., 1997, Frankel et al., 1996, Lawlor et al., 2005, Huxley et al., 2007, 
Eriksson et al., 1999). Additionally, several related conditions have been shown to be 
inversely associated with birth size, including type 2 diabetes (Lithell et al., 1996, 
Forsén et al., 2000, Whincup et al., 2008, Kajantie et al., 2010), stroke (Rich-Edwards 
et al., 1997, Lawlor et al., 2005, Eriksson et al., 2000), the metabolic syndrome (Nobili 
et al., 2008, Fagerberg et al., 2004), and hypertension (Barker et al., 1989a, Lenfant, 
2008, Curhan et al., 1996). There have also been studies linking a small size at birth 
with renal disease (Vikse et al., 2008) hypothyroidism (Kajantie et al., 2006), 
osteoporosis (Baird et al., 2011), and depression (Gale and Martyn, 2004, Paile-
Hyvärinen et al., 2007). A large birth size, on the other hand, has been linked to 
obesity (Curhan et al., 1996), rheumatoid arthritis (Mandl et al., 2009), and various 
cancers (McCormack et al., 2005). All-cause mortality was demonstrated to be 
inversely associated with birth weight in a large review and meta-analysis (Risnes et 
al., 2011). 
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Table 1. Conditions associated with low and high birth weight. 
Low birth weight High birth weight 
Coronary heart disease Obesity 
Type 2 diabetes Rheumatoid arthritis  
Hypertension Certain cancers   
Stroke   
Insulin resistance   
Metabolic syndrome   
Renal disease   
Hypothyroidism   
Osteoporosis    
Depression   
Sarcopenia   
Premature mortality   
 
There are several studies focusing upon the associations between postnatal growth and 
later health and disease risk. A slow growth in infancy, followed by a faster growth in 
later childhood, has been linked to an increased risk of CHD (Eriksson et al., 2001, 
Barker et al., 2005, Eriksson et al., 1999), and type 2 diabetes (Forsén et al., 2000). 
Conversely, a rapid postnatal growth has also been linked to an increased risk of 
obesity (Tzoulaki et al., 2010, Ong et al., 2000). One study, focusing on obese 
individuals, reported that those who developed the metabolic syndrome as adults were 
smaller than their peers from age 2 to 11 years (Salonen et al., 2009a) whereas another 
study showed that low birth weight, in combination with accelerated catch-up growth 
between birth and age 18 years, was positively associated with the metabolic syndrome 
(Fagerberg et al., 2004). A slow weight gain between birth and age 2 years and small 
attained body size at age 2 years has been shown to be associated with an increased 
risk of stroke (Osmond et al., 2007). Unfortunately, studies on childhood growth are 
difficult to compare, due to differences in methodology in regards to how and which 
aspect of growth is measured, as well as which age ranges have been studied. A large 
study, analysing data from four prospective cohorts, demonstrated an increased 
cardiovascular risk in individuals who were obese in both childhood and adulthood 
(Juonala et al., 2011). Obese children who were subsequently non-obese as adults, 
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however, had a similar adult risk to that of individuals who were never obese. 
Although this study did not account for prenatal growth, it still demonstrates the 
importance of a life-course approach when evaluating cardiovascular risk.  
 
Programming 
 
The associations between birth size and later health have been demonstrated for both 
men and women, people of different ethnicity and in different age groups, 
independently of current exercise level and body composition. Animal studies have 
been essential in elucidating the underlying mechanisms of the association between 
early development and later health outcomes. Birth size reflects intrauterine growth 
and development – a small birth size often reflects a suboptimal intrauterine 
environment. In addition to nutritional factors, highlighted in the early studies in the 
DOHaD field, fetal development is affected by a number of other circumstances, 
including maternal hormonal and metabolic factors, placental function, and external 
environmental exposures (e.g. high altitude, maternal smoking) (Fowden et al., 2006). 
It is important to note that intrauterine challenges are not always associated with 
reduced fetal growth and low birth weight (Gluckman and Hanson, 2006a). Epigenetic 
modification of non-imprinted genes, affecting gene expression and bringing about 
phenotypic changes, is thought to be a key mechanism underlying the intrauterine 
environment’s influence on the developing fetus. Fetal responses to the intrauterine 
environment are called fetal adaptive responses and take place during plastic periods of 
development. Based on environmental cues, fetal development adapts to correspond to 
the predicted postnatal environment. These adaptations can have immediate beneficial 
effects and promote survival in the short term but can also lead to increased disease 
susceptibility in the long term (Gluckman and Hanson, 2004, Gluckman et al., 2005).  
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Figure 1. Pathways of programming.  
 
 
 
 
 
 
HPA axis: Hypothalamic-pituitary-adrenal axis.  
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2.2 Body composition and resting metabolic rate  
 
2.2.1 Assessment of body composition 
 
Measurement of body mass index (BMI, kg/m2) is, albeit crude, a useful method of 
assessing overweight and obesity – both in the clinical setting, and at the population-
level (World Health Organization, 2000). BMI, however, does not distinguish between 
fat mass (FM) and fat-free mass (FFM), and neither does it assess the distribution of 
fat mass. It is, however, strongly associated with cardiovascular risk and in many 
aspects comparable to measurements specifically addressing central obesity, e.g. waist 
circumference and waist-hip ratio (WHR) (Huxley et al., 2010). The review by Huxley 
and colleagues concluded that there was some evidence of a stronger association with 
risk for the measurements of central obesity compared to BMI in the case of type 2 
diabetes, but that no such difference was seen for dyslipidaemia and hypertension. 
Other methods of assessing central obesity include android/gynoid ratio and 
measurement of sagittal abdominal diameter (SAD). A higher android/gynoid value 
indicates greater fat distribution intra-abdominally than at the hips. SAD measures the 
distance between the small of the back and the upper abdomen. A greater value 
indicates an increased risk of coronary disease, independent of BMI. 
 
Several methods, including, but not limited to, hydrostatic (underwater) weighing 
(HW), dual-energy x-ray absorptiometry (DEXA), magnetic resonance imaging 
(MRI), magnetic resonance spectroscopy (MRS), dilution techniques, and bioelectrical 
impedance analysis (BIA), are available for more detailed assessment of body 
composition (Lee, 2008). HW is considered the gold standard method and, based on 
Archimedes’ principle, estimates whole-body density by measuring the difference 
between a subject’s underwater weight and weight in air (Biaggi et al., 1999). Apart 
from BIA and, to a lesser degree, DEXA, the methods described above are impractical 
in larger epidemiological settings, as they are expensive, and time consuming. BIA 
estimates the total body water pool by sending a small electrical current through the 
body and measuring its impedance. FFM is then calculated based on the assumption 
that 73% of the body’s FFM consists of water (Lee, 2008). There are several different 
types of BIA devices available, e.g. single frequency devices with four electrodes and 
multi-frequency devices with eight electrodes. In a validation study against DEXA and 
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HW, the most precise estimates were found for the multi-frequency device (Demura et 
al., 2004). Total body fat can also be estimated by measurement of skinfold thickness, 
a simple method requiring only the use of calipers. The method is primarily used in 
children. Compared to other measurements of body composition, there are more 
pronounced validity issues. Nevertheless, the method can be used for estimating the 
degree of fatness in groups, as well as in individuals, to obtain indices, rather than 
measures, of body fat (Reilly et al., 1995).  
 
2.2.2 Resting metabolism – background and assessment 
 
Resting metabolic rate (RMR) accounts for about 80% of energy expenditure in 
sedentary individuals (Landsberg et al., 2009). It has been suggested that a low RMR 
is a contributing factor in the development of obesity but results have been 
contradictory. Whereas some longitudinal studies have reported an association 
between low energy expenditure in infancy, childhood and adulthood, and later weight 
gain and obesity development (Roberts et al., 1988, DeLany et al., 2006, Ravussin et 
al., 1988, Tataranni et al., 2003), others have not (Stunkard et al., 1999, Goran et al., 
1998, Weinsier et al., 1995). A meta-analysis of studies focusing on the RMR of 
formerly obese individuals showed that these had a RMR that is 3‒5% lower than 
controls, after adjustment for differences in FM and FFM. This could potentially 
contribute to the tendency of weight regain among formerly obese individuals (Astrup 
et al., 1999).   
 
Several methods of various complexity are available for the assessment of energy 
expenditure. BIA, described above, can be used for estimation of RMR by predictive 
equations based on the measurement of FFM. Other methods include direct and 
indirect calorimetry and various predictive equations. The first predictive equations, 
based on age, sex, weight, and height were published in the beginning of the 20th 
century and several alternative ones have since been developed. Direct calorimetry 
measures the heat exchange between body and environment. It requires a hermetically 
sealed isolation chamber and confines the examined individual for 24 hours or more 
making it both costly and difficult to use in a wider setting. Indirect calorimetry, while 
still expensive, allows for short-term measurement of energy expenditure. It measures 
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heat expended by nutrient oxidation indirectly, by monitoring oxygen consumption 
and carbon dioxide production (Pinheiro Volp et al., 2011).  
 
2.2.3 Size at birth, childhood growth and adult body composition 
 
It is well established that birth weight is positively associated with adult FFM 
(Sachdev et al., 2005, Gale et al., 2001, Sayer et al., 2004, Ylihärsila et al., 2007, 
Singhal et al., 2003). Birth weight has been demonstrated to be inversely associated 
with adult FM after adjustment for adult BMI (Ylihärsila et al., 2007) in men and 
women aged 56 to 70 years, as well as inversely associated with android/gynoid ratio 
in men and women aged 60 to 64 years (Bann et al., 2014). Bann and colleagues 
additionally reported a positive association between weight gain in infancy and adult 
lean body mass whereas later weight gain additionally predicted higher FM and higher 
android/gynoid and fat/lean ratios. Height gain throughout childhood was positively 
associated with adult lean body mass and inversely with android/gynoid and fat/lean 
ratios. Similar findings in regards to childhood growth patterns have been reported 
from the New Delhi Birth Cohort where higher levels of BMI and greater BMI 
increase during late childhood and adolescence were associated with higher degrees of 
adiposity at ages 26‒32 years (Adair et al., 2013).  
 
2.2.4 Size at birth and adult resting metabolic rate 
 
A relatively small number of studies have examined the associations between birth size 
and adult resting metabolic rate. A study from the 1924‒33 Helsinki Birth Cohort 
Study (n = 318) demonstrated an inverse association between birth weight and RMR 
expressed per unit of FFM (Eriksson et al., 2002). Similar results have also been 
reported in a study of young non-diabetic Pima Indians ( n = 272), a population known 
for high prevalence for type 2 diabetes and obesity (Weyer et al., 2000). In a study 
from the Helsinki Study of Very Low Birth Weight Adults, the resting energy 
expenditure/lean body mass ratio was 6.1% higher in the study population (n = 116) 
compared to controls (n = 118) (Sipola-Leppänen et al., 2011). Mean age in this study 
was 22.5 years. A small study (n = 29) on healthy men aged 64‒72 years by Kensara 
and colleagues demonstrated lower resting energy expenditure in individuals with birth 
weights below the 25th percentile compared to those with birth weights above the 75th 
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percentile, after adjustment for adult height and weight (Kensara et al., 2006). Results 
from a relatively small case-control study (n = 59) demonstrated that infants born to 
mothers with well-controlled diabetes had reduced resting energy expenditure and fat 
oxidation compared to controls 30‒40 days post partum (Short et al., 2015).  
 
2.3 Non-alcoholic fatty liver disease (NAFLD) 
   
2.3.1 Definition, prevalence, and pathogenesis 
 
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver 
disease in developed countries with a prevalence of 20‒30 % (Bellentani et al., 2010, 
Loomba and Sanyal, 2013). It is frequently referred to as the hepatic manifestation of 
the metabolic syndrome (Marchesini et al., 2001) and is closely associated with type 2 
diabetes, obesity and morbid obesity (Musso et al., 2011, Nakao and Yoneda, 2009), 
with a prevalence of 70%, 57%, and 90% with these conditions, respectively (Gaggini 
et al., 2013). Furthermore, ectopic fat accumulation, i.e. lipid accumulation in the liver, 
skeletal muscle and other insulin-sensitive tissues, would seem to be associated with 
insulin resistance independent of obesity (Yki-Järvinen, 2002). NAFLD is defined as a 
liver fat content exceeding 5‒10% of liver mass, in absence of other liver disease or 
excessive alcohol intake (Puri and Sanyal, 2012). It is a continuum of conditions 
including simple steatosis, non-alcoholic steatohepatitis (NASH), fibrosis, and 
cirrhosis (Than and Newsome, 2015).  
 
Figure 2. Factors associated with NAFLD 
Metabolic syndrome 
Obesity 
Type 2 diabetes 
Total parenteral nutrition 
Jejunoileal bypass operation 
Use of specific medication 
Dietary factors, potentially including high intake of fructose  
 
The pathogenesis of NAFLD is described by a “multi-hit” hypothesis and involves the 
complex interplay of several factors with special emphasis on insulin resistance (Lewis 
and Mohanty, 2010). In the insulin resistant state, lipolysis in peripheral adipose tissue 
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leads to an increased influx of free fatty acids to the liver, resulting in hepatic lipid 
accumulation and a stimulation of de novo lipogenesis, representing the first hit. 
Several second hits, e.g. inflammatory cytokines, dysregulated apoptosis, and reactive 
oxygen species, are involved in the progression of the disease. (Than and Newsome, 
2015, Lewis and Mohanty, 2010).  
 
2.3.2 Diagnosis of NAFLD 
 
The gold standard diagnostic method, liver biopsy, is currently the only method able to 
tell simple steatosis and NASH apart (Palekar et al., 2006). Imaging techniques, 
including ultrasonography, MRI, MRS, and computer tomography (CT) can also be 
used to diagnose NAFLD, but only in the assessment of hepatic fat content (Roldan-
Valadez et al., 2008). The above methods are all relatively costly, time consuming and 
in the case of liver biopsy associated with a small degree of procedure-related 
morbidity and rarely even mortality (Weigand and Weigand, 2009). In comparison, 
recently developed algorithm scores, based on readily available clinical and 
biochemical markers, offer an attractive alternative in the setting of large 
epidemiological studies. 
 
2.3.3 Developmental origins of NAFLD 
 
During recent years, a number of studies have explored the developmental origins of 
NAFLD. Evidence from animal studies show that both maternal undernutrition and 
overnutrition are associated with the development of NAFLD. A recent study on rats 
showed that female rats exposed to nicotine in utero, in order to induce intrauterine 
growth retardation (IUGR), were at a higher risk of developing diet-induced NAFLD 
in adulthood (Xu et al., 2015). Similar findings have been reported for rats prenatally 
exposed to caffeine and ethanol, respectively (Wang et al., 2014a, Shen et al., 2014). 
In mice, maternal high fat diet (HFD), as well as maternal obesity, have been linked to 
NAFLD in the offspring (Bruce et al., 2009, Pruis et al., 2014, Oben et al., 2010, 
Mouralidarane et al., 2013). 
 
In human studies, IUGR has been demonstrated to be associated with pediatric 
NAFLD (Nobili et al., 2007). MRI studies of newborn infants have demonstrated that 
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maternal BMI is positively associated with intrahepatocellular lipid content in the 
offspring (Brumbaugh et al., 2013, Modi et al., 2011). The risk of developing NAFLD 
is also influenced by childhood growth patterns. In one study, assessing the prevalence 
of NAFLD using the fatty liver index (FLI) algorithm test, an accelerated gain in 
weight-for-height from birth to age 3 months was associated with higher NAFLD risk 
at mean ages 18‒24 years. No associations with birth weight were found, however 
(Breij et al., 2014). Greater rates of weight-for-height gain between ages 1 and 10 
years have also been linked to liver fat content and liver stiffness as assessed by 
ultrasonography, as well as higher levels of blood-based markers of liver disease at 
mean age 17.8 years (Anderson et al., 2014). After adjusting for fat mass, these 
associations attenuated towards the null. Another study demonstrated that adiposity 
attained from age 3 years and onwards was associated with diagnosis and severity of 
NAFLD, as assessed by ultrasonography at mean age 17 years (Ayonrinde et al., 
2015).  
 
2.3.4 Fructose and NAFLD 
 
Fructose intake has been implicated as a potential risk factor in the development of 
NAFLD. Fructose is primarily metabolized in the liver and provides substrates for 
gluconeogenesis, glycolysis, and de novo lipogenesis (DNL). The fatty acids created 
through DNL are incorporated into triglycerides that can be secreted as very low 
density lipoproteins (VLDL). If this process is impaired, triglycerides can accumulate 
intracellularly leading to steatosis (Neuschwander-Tetri, 2013, Vos and Lavine, 2013). 
Rodent studies have demonstrated that a high fructose diet induces NAFLD and also 
leads to increased serum levels of aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), triglycerides, and total cholesterol (de Castro et al., 2013, 
Ackerman et al., 2005). However, animal models studying the associations between 
fructose and NAFLD have been criticized for featuring supraphysiological levels of 
fructose intake (Chiu et al., 2014). In a recent review and meta-analysis of six 
observational and 21 intervention studies in humans, the authors conclude that the 
associations between intake of fructose and sucrose and various indices of liver health 
(e.g. liver fat content, hepatic DNL, and serological markers) is possibly confounded 
by excessive energy intake (Chung et al., 2014). Another recent review, focusing on 
controlled feeding diets, reached similar conclusions. Here, no evidence was found that 
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fructose induced NAFLD in studies where it isocalorically replaced other carbohydrate 
sources. In hypercaloric studies, where fructose was administered in high doses, 
intrahepatocellular lipids and ALT did increase, an effect that might be attributable to 
excessive energy intake rather than to fructose (Chiu et al., 2014).   
 
2.4 Hypertension 
 
2.4.1 Definition, prevalence, and pathogenesis 
 
Hypertension is present in adults when the average of multiple measurements of 
systolic blood pressure on at least two different occasions is ≥ 140 mmHg or the 
average of at least two measurements of diastolic blood pressure on at least two 
different occasions is ≥ 90 mmHg (Carretero and Oparil, 2000). The prevalence of 
hypertension in Western countries is estimated to be 30‒45% (Mancia et al., 2013, 
Centers for Disease Control Prevention, 2011). The pathogenesis of essential 
hypertension is complex, multifactorial and only partly known. Several factors with 
various degrees of interplay have been suggested in the development of the condition, 
including, but not limited to, various genetic factors, high sodium intake, overactivity 
of the renin-angiotensin-aldosterone system, increased sympathetic tone, obesity, 
diabetes mellitus, low nephron number, and insulin resistance (Suzanne and Amin, 
2003, Johnson et al., 2008).  
 
 
Figure 3. Some conditions involved in the development of hypertension 
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2.4.2 Developmental origins of hypertension 
 
Birth size 
 
A large number of studies have explored the association between body size at birth and 
later blood pressure. In a systematic review by Huxley and colleagues, including 
eighty studies and more than 444000 men and women aged 0‒84 years, a one kg 
higher birth weight was estimated to be associated with 2 mmHg lower systolic blood 
pressure (Huxley et al., 2000). However, in a subsequent review, also written by 
Huxley and colleagues, this conclusion was called into question. Here, the authors 
suggested that the inverse association between birth weight and later blood pressure 
might primarily reflect publication bias, random error and inappropriate adjustment for 
current weight and potential confounding factors (Huxley et al., 2002). A review of 55 
studies including more than 382000 men and women aged 0‒75 years, supported the 
suggestion of publication bias but found that the inverse association between birth 
weight and later systolic blood pressure remained significant despite adjustment for 
this bias (Schluchter, 2003). A more recent meta-analysis, including both published 
and unpublished data on almost 200000 individuals from 20 Nordic cohorts, once 
again showed an inverse association between birth weight and later systolic blood 
pressure (Gamborg et al., 2007). Importantly, this association remained significant 
despite adjustment for current BMI and was stronger in older age groups. The latter 
could potentially either be caused by a birth cohort effect, or be due to amplification, 
described below. Lastly, the review demonstrated a sex-difference in the association 
between birth weight and blood pressure. Whereas the association was linear and 
inverse for the entire range among men, it became positive in birth weights above 4 kg 
in women. Additionally, the association was stronger in women than in men. For 
example, the effect of birth weight on systolic blood pressure at age 50 years was 
estimated to be -2.80 mmHg/kg in women and -1.52 mmHg/kg in men. A meta-
analysis of 20 studies published between 1998 and 2011 applied a dichotomized 
approach to assess the association between birth weight and systolic blood pressure. In 
this study, a birth weight below 2500 grams was associated with 2.28 mmHg higher 
systolic blood pressure, compared to individuals with birth weights above 2500 grams. 
A birth weight above 4000 grams was associated with 2.08 mmHg lower systolic 
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blood pressure, compared to individuals with birth weights below 4000 grams (Mu et 
al., 2012).  
 
Amplification 
 
The association between birth weight and blood pressure has been suggested to 
amplify with age, meaning that the most pronounced age-related blood pressure 
increase should be seen in those with the lowest birth weights. In a pooled analysis of 
one longitudinal study of children and three follow-up studies of adults, Law et al 
demonstrated that the magnitude of the association between birth weight and systolic 
blood pressure increases with age from childhood to adulthood (Law et al., 1993). A 
longitudinal study of 584 men and women from Adelaide, Australia, found a stronger 
influence of birth weight on systolic blood pressure at age 20 years, compared to age 8 
years, supporting the amplification hypothesis (Moore et al., 1999). In a study from the 
1946 British Birth Cohort, 3634 men and women were examined at ages 36, 43, and 
53 years. Systolic blood pressure increased 1 mmHg for every 10 year increase in age 
but this was largely accounted for by current BMI (Hardy et al., 2003). Conversely, a 
more recent study, from the Bogalusa Heart Study, including 6251 individuals (64.5% 
white, 35.6% black, 50% male) with up to 15 examinations of blood pressure from 
childhood to adulthood, demonstrated increased magnitude in the association between 
birth weight and systolic blood pressure, regardless of adjustment for current BMI 
(Chen et al., 2010). Further support for the amplification hypothesis has been found in 
cross-sectional (Davies et al., 2006) and meta-regression analysis studies (Gamborg et 
al., 2007).  
 
Growth in infancy and childhood 
 
Several studies, including individuals of various ethnicity and age groups, have 
explored the influence of growth patterns in infancy and childhood on later blood 
pressure. In a study of 102 three-year-old boys and girls, systolic blood pressure was 
positively associated with current weight as well as weight gain based on birth weight. 
Systolic blood pressure was 0.2 mmHg higher per 100 grams of current weight and 1.5 
mmHg higher per 100-unit increase in conditional weight gain, defined as difference in 
growth between birth and age 3 years divided by growth at birth. No association was 
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demonstrated with birth weight, however (Min et al., 2007). Findings from the Avon 
Longitudinal Study of Parents and Children (ALSPAC) indicate that later childhood 
growth has a greater influence on blood pressure, compared to prenatal growth and 
growth in infancy. Inverse associations with systolic blood pressure at age 10 years 
were found for birth weight and weight-for-height, but not for birth length. 
Conversely, gains in height, weight, and weight-for-height in infancy and later 
childhood, as measured using conditional modelling, were all positively associated 
with systolic blood pressure at age 10 years. For later childhood conditional height, 
weight, and weight-for-height conditional variables, systolic blood pressure increased 
1.91, 1.56, and 1.20 mmHg per SD of the conditional variables, respectively. Similar, 
but weaker associations were demonstrated for diastolic blood pressure (Jones et al., 
2012). These findings were expanded upon by Chiolero et al, who in a letter to the 
editor demonstrated a stronger influence of conditional weight gain between ages 12.5 
– 15.5 years, compared to weight gain between 1 and 12.5 years, on systolic blood 
pressure at age 15.5 years, supporting the hypothesis that blood pressure is more 
responsive to current, rather than earlier, weight change (Chiolero et al., 2012). A 
study of 1284 Danish men born between 1936 and 1970 from Gamborg et al compared 
four models of assessing the association between growth and later blood pressure: 
simple linear regression, multiple linear regression, conditional linear regression, and 
path analysis. Path analysis is an extension of regression analysis. In the context of the 
above study, it was used to analyse the associations between body sizes at various ages 
as well as the associations between systolic blood pressure and all body sizes. The 
main findings were that path analysis produced better statistical power than the other 
methods and, in agreement with previous findings, that the effect of change in relative 
body size on adult systolic blood pressure, was more pronounced after age 11 years, 
compared to changes in earlier childhood (Gamborg et al., 2009). In a study from the 
1934‒44 Helsinki Birth Cohort Study, including 2003 individuals at mean age of 62 
years, two paths of growth were identified among hypertensive individuals. The first 
group, who were already diagnosed with hypertension at the commencement of the 
clinical study, were born thin and short, grew slowly up until age 2 years and thereafter 
grew more rapidly, ending up with an average body size at age 11 years. The second 
group, who were not previously diagnosed with hypertension but had blood pressures 
within the hypertensive range when visiting the clinic, were short at birth and grew 
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slowly throughout childhood, ending up short and thin at age 11 years (Eriksson et al., 
2007).  
 
Potential mechanisms for the association between early growth and hypertension 
 
The underlying mechanisms of the association between birth weight and blood 
pressure are only partly understood. Low birth weight and prematurity have been 
demonstrated to be associated with a reduced number of nephrons at birth, which in 
turn is associated with an increased risk of adult hypertension and susceptibility to 
renal disease (Luyckx et al., 2013). In a study examining autopsied kidneys from 56 
individuals, a linear association was found between birth weight and nephron number 
with a regression coefficient predicting an increase of more than 250000 nephrons per 
kg of birth weight (Hughson et al., 2003). Furthermore, rapid childhood weight and 
BMI gain, especially following a low birth weight, has been suggested to contribute to 
a faster progression of renal disease (Luyckx et al., 2013). Early programming of the 
hypothalamic-pituitary-adrenal axis (HPAA) has also been implicated as a potential 
contributor in the association between birth weight and adult blood pressure. In a 
composite study, including 165 men and women born in Adelaide, South Australia, 
between 1975 and 1976, 199 men and women born in Preston, UK, between 1935 and 
1943, and 306 women born in East Hertfordshire, UK, between 1923 and 1930, a low 
birth weight was associated with raised fasting plasma cortisol concentrations in all 
three cohorts. Furthermore, fasting plasma cortisol was associated with increased 
blood pressure, most markedly so among obese individuals (Phillips et al., 2000). In a 
study comparing normal birth weight children (n = 37) with children born small for 
gestational age (SGA) (n = 29), and preterm children (n = 39) at mean age 9.6 years, 
dopamine, adrenaline, and noradrenaline concentrations in urine were significantly 
higher in SGA and preterm children compared to controls. Furthermore, heart rate was 
higher both at rest and after mental stress (mathematical test) among SGA and preterm 
children compared to the controls (Johansson et al., 2007). 
 
2.5 Regional differences in health and disease 
   
The prevalence of NCDs show both within- and between-country variation. The 
background of this variation is multifactorial with contributions from e.g. genetic, 
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socioeconomic, environmental, and dietary factors, as well as general education level, 
historical context, and several other factors. As previously noted, Barker and 
colleagues demonstrated a strong geographical association between infant mortality 
during the years 1921‒25 and ischaemic heart disease mortality 43‒57 years later 
(Barker and Osmond, 1986). In a 2007 study including almost 18000 mostly white, 
apparently healthy men aged 40‒80 years from the US Physicians Health Study, no 
regional differences were found for risk of major CVD. However, the risk of total 
stroke and ischemic stroke was associated with living in the Southeast, compared to 
the rest of the US, after adjustment for traditional CVD risk factors (Rich et al., 2007).  
 
In Finland, the Swedish speaking minority accounts for 5.5% of the population. In a 
large register study from 2003, the age-standardized relative mortality was lower 
among Swedish-speaking women, compared to Finnish-speaking (0.93). After 
adjustment for socio-economic and geographical factors, these differences 
disappeared. In men, the relative age-standardized mortality was 0.73 among Swedish-
speakers. After adjustments, this attenuated to 0.83 with the remaining difference 
primarily explained by non-natural deaths and cardiovascular mortality among 
Finnish-speaking men (Koskinen and Martelin, 2003). In another study, poor self-rated 
health was found to be less common among Swedish-speaking than Finnish-speaking 
Finns (Hyyppä and Mäki, 2001). Within Finland, there have been marked differences 
in health between the western and eastern part of the country. In the 1980s, eastern 
Finland had the highest CHD mortality rates in the world with significantly lower 
incidence in western Finland (Tunstall-Pedoe et al., 1994). Although the situation has 
since improved, more recent studies have shown persistent differences between east 
and west Finland in regards to cardiovascular risk factors (Juonala et al., 2004). 
Differences in early life living conditions and parental socioeconomic status may 
partly explain this geographical difference. In a longitudinal study comparing 823 men 
born in 1900‒1919 in eastern Finland with 888 men born in the western part of the 
country, those born landless, i.e. to parents not owning land, in eastern Finland had 
systematically increased relative risk of cardiovascular mortality and morbidity 
(Notkola et al., 1985). A more recent study based on the same cohort demonstrated 
that men born in western Finland were significantly taller than those born in eastern 
Finland (Forsen et al., 2000). Cardiovascular morbidity and mortality was inversely 
associated with height. Interestingly, no geographical differences in the cardiovascular 
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outcomes were seen in men above 172 cm in height. These findings indicate that the 
geographical differences in Finnish health might have developmental origins, as a 
higher attained adult stature is a sign of a beneficial intrauterine and postnatal 
environment.  
 
The Åland Islands, an autonomous province of Finland consisting of around 6000 
islands, were recently ranked as Finland’s healthiest region according to a composite 
index of disease prevalence developed by the Finnish National Institute of Health and 
Welfare. The islands received a composite score of 68.9 (the national mean is set at 
100) with significantly lower scores than the national mean for five of the seven 
included disease categories: CHD, psychiatric disease, dementia, accidents, and 
musculoskeletal disorders. The scores for the remaining two categories, 
cerebrovascular disease and cancer, were not significantly different from the national 
mean (Terveyden ja hyvinvoinnin laitos (Finnish National Insititute for Health and 
Welfare), 2012). In 2005‒09, the mean life expectancy at birth for Ålandic men was 
79.7 years, 3.2 years longer than for men living on the mainland. For women, the 
corresponding figure was 83.9 years, the same as for mainland peers. Furthermore, 
Ålandic women have the longest prospected remaining years alive at age 80 years in 
the Nordic countries, with a mean of an additional 10 years (NOMESCO (Nordisk 
Medicinalstatistisk Komité), 2011). Historically, mean life expectancy at birth has 
been higher on the Åland Islands than in the rest of Finland from the second quarter of 
the 19th century and at least until the beginning of the 20th century (Mielke et al., 
1987). 
! 40!
3 AIMS OF THE STUDY 
 
The primary aim of this study was to explore aspects of the developmental origins of 
health and disease hypothesis from a public health perspective by studying 
associations between early growth and a number of health outcomes directly or 
indirectly related to common non-communicable diseases, specifically features of the 
metabolic syndrome, including non-alcoholic fatty liver disease and hypertension. 
Secondary aims included exploring the association between fructose intake and the 
presence of non-alcoholic fatty liver disease, as well as comparing birth records from 
the Helsinki Birth Cohort Study with contemporaneous births on the Åland Islands.  
 
The specific objectives were: 
 
1. To assess the association between birth weight and adult resting metabolic rate, 
also taking current body composition into account (Study I). 
 
2. To explore the associations between childhood growth and adult non-alcoholic 
fatty liver disease (Study II). 
 
3. To explore the influence of fructose intake on non-alcoholic fatty liver disease  
(Study III). 
 
4. To explore the associations between childhood growth and adult blood pressure 
and to assess whether this association amplifies with age (Study IV). 
 
5. To compare birth weights from the Helsinki Birth Cohort Study with 
contemporaneous births on the Åland Islands as a first step in a future potential 
analysis of Ålandic health and longevity from a life-course perspective (Study V). 
 
! 41!
4 SUBJECTS AND METHODS 
 
4.1 The Helsinki Birth Cohort Study 
 
The Helsinki Birth Cohort Study (HBCS) consists of two birth cohorts, one comprising 
7086 individuals born 1923‒33 and the other one comprising 13345 individuals born 
1934‒44. All participants of the older cohort, and 8760 participants (66%) of the 
younger were born in the Helsinki University Central Hospital (HUCH). The 
remaining 34% of the younger cohort were born in the Helsinki City Maternity 
Hospital (HCMC). The studies included in this thesis are based on the younger cohort 
only. The study participants attended child welfare clinics in the city of Helsinki and 
the majority also went to school there. All were alive in 1971 when residents in 
Finland received a unique identification number, allowing for tracing and inclusion 
into the cohort study.  
 
The birth records include information on birth weight, length, head circumference, and 
placental measurements. Ponderal index at birth was calculated for all participants by 
dividing birth weight in kg by birth length in metres cubed (kg/m3). The birth records 
additionally include information on maternal age, parity, last menstrual period, and 
weight and length prior to delivery. Child welfare clinic records include serial weight 
and length/height measurements through infancy and early childhood. School records 
include weight and height measurements from ages 7 to 12 years. An average of 18 
measurements of weight and length/height are available from birth to age 12 years. In 
addition, the records include information on living conditions and paternal (and in 
some cases maternal) occupation. Childhood socioeconomic status was determined 
based on paternal occupation using three categories (labourer, lower middle and upper 
middle class) based upon an original classification by Statistics Finland. 
 
7079 study participants born in HUCS 1934‒44 were still alive in 2000 and were sent 
a questionnaire based on questions used in the Health 2000 and FINRISK studies. The 
questionnaire included questions relating to the respondents’ health status, medication, 
height and weight, lifestyle, socioeconomic circumstances, and parental background. 
4515 of those who received the questionnaire replied and out of these, 2902 were 
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selected by use of random number tables for invitation to a clinical study. 2003 of 
these (928 men and 1075 women) accepted the invitation and were included in the 
clinical study which took place in 2001‒04. A follow-up study, including 1083 
individuals (486 men and 597 women) without diagnosis of type 2 diabetes at the time 
of the first clinic visit, took place in 2006‒08.  
 
Figure 4. Flow chart describing distribution of subjects in studies I‒V. 
 
HBCS: Helsinki Birth Cohort Study; HCMC: Helsinki City Maternity Hospital; HUCH: Helsinki 
University Central Hospital; RMR: Resting metabolic rate; FFM: Fat-free mass; NAFLD: non-alcoholic 
fatty liver disease; BP: blood pressure. 
 
4.2 Åland birth records 
 
The Åland birth records are based on official birth certificates collected between 1885 
and 1998. In the context of study V, records from the years 1937‒44 were included. 
For these years, the data set includes 1803 births. Records for the years 1934‒36 only 
consisted of birth records from three out of Åland’s thirteen parishes, and consequently 
were not included. After further exclusions due to missing data on child sex, missing 
data on both birth weight and length, stillbirth, twin birth, and one individual with an 
! 43!
impossible live birth weight (200 grams), the remaining number of individuals 
included in the study were 1697 (877 men and 820 women). Information on birth 
weight was available for all but one subject, and information on birth length was 
available for 1551 individuals. In addition, information on maternal age and maternal 
marital status was available for the majority of the subjects.   
 
4.3 Adult characteristics 
 
The subjects attended the clinic after an overnight fast. Participants provided written 
informed consent before the examination took place. All measurements were 
performed by trained study nurses. 
 
Anthropometry 
 
Weight was measured in light clothing without shoes to the nearest 0.1 kg, height was 
measured to the nearest 0.1 cm. BMI was calculated by dividing weight in kilograms 
by the square of height in metres (kg/m2). Waist circumference was measured halfway 
between the lowest rib and the iliac crest. 
 
Blood pressure 
 
Blood pressure was measured from the right arm with the participant in a sitting 
position using a standard sphygmomanometer. The mean of two measurements was 
recorded. 
 
Body Composition 
 
The Inbody 3.0 eight-polar tactile electrode system (Biospace Co Ltd, Seoul, Korea) 
was used in study I for bioelectrical impedance (BIA) measurement of body 
composition. This method estimates fat mass and fat-free mass through segmental 
impedance measurement for the trunk as well as each limb at four electrical 
frequencies (5, 50, 250, and 500 kHz). It has been found to give accurate estimates of 
body composition when validated against dual-energy x-ray absorptiometry and 
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measurements of total body water by use of bromine and deuterium dilution (Sartorio 
et al., 2005, Kushner et al., 1990, Malavolti et al., 2003).  
 
Resting metabolism 
 
The Datex Deltatrac™ device (Helsinki, Finland) was used in study I for measurement 
of resting metabolic rate (RMR), expressed as total kilocalories expended/24 hours. 
The device measures oxygen consumption and carbon dioxide production through a 
transparent plastic canopy. These measurements are used in the calculation of 
respiratory quotient and energy expenditure. The test was recorded after an overnight 
fast for 40 minutes, 10 minutes of which were discarded as acclimatization artefact. 
The device has been described elsewhere in detail (Meriläinen, 1987). Only 
individuals who underwent both measurement of body composition and resting 
metabolism were included in study I (n = 896, 408 men and 488 women). 
 
Laboratory methods 
 
Fasting plasma (fP)-glucose was measured using a hexokinase method (Kunst et al., 
1984). A 2-site immunometric assay was used to measure fasting serum (fS)-insulin 
(Sobey et al., 1989). fS-AST, fS-ALT, and fS-γ–glutamyl transferase (GGT) were 
measured through a photometric International Federation of Clinical Chemistry (IFCC) 
method using an Architect ci 82000 analyser (Abbott Laboratories). High density 
lipoprotein (HDL) and triglyceride concentrations were measured using standard 
enzymatic methods (Lie et al., 1976, Fossati and Prencipe, 1982). Laboratory tests also 
included a standard 75 g oral glucose tolerance test (OGTT).  
 
Questionnaires 
 
Information on leisure-time physical activity, smoking status, marital status, 
medication, and medical history was obtained from a self-administered questionnaire. 
Individuals with a moderate physical activity, defined as brisk walking or comparable 
activity, at least three times per week, were defined as physically active. Those who 
smoked at least one cigarette per day were defined as smokers.  
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The participants additionally completed a validated food-frequency questionnaire 
(FFQ) (Männistö et al., 1996, Paalanen et al., 2006) measuring habitual diet over a 
one-year period. The FFQ included 128 items with pre-defined sex-specific sizes. 
Participants entered frequency of consumption of each item according to nine 
categories: from never or seldom to ≥ 6 times per day. Average intake of nutrients, 
foods, and energy intake were calculated using the Finnish National Food Composition 
Database (Fineli) and in-house software (Reinivuo et al., 2010). Based on the FFQ 
results, daily energy intake (kJ/d) and alcohol intake (g/d) were estimated. Study III 
additionally included estimation of daily intake of fat (g/d), fiber (g/d), vitamin E 
(alphatocopherol equivalents in mg/d), and fructose (g/d). In study IV, daily sodium 
intake (g/d) was estimated from FFQ data.  
 
Socioeconomic status 
 
In study II, adult socioeconomic status was based on occupation and derived from 
1980 census data. In study IV, adult socioeconomic status was derived from census 
data collected every fifth year from 1970 to 2000. 
 
Definition of hypertension 
 
Hypertension diagnosis was based on the use of antihypertensive medication, 
according to either questionnaire information or register data of reimbursement, and/or 
systolic blood pressure values ≥ 140 mmHg and/or diastolic blood pressure values  
≥ 90 mmHg.  
 
Definition of type 2 diabetes 
 
Type 2 diabetes diagnosis was based on current use of diabetes medication and/or on 
the 1999 WHO criteria, i.e. fP-glucose ≥ 7.0 mmol/l at two different occasions (one 
measurement sufficient if concurrent symptoms) and/or plasma glucose ≥ 11.1 mmol/l 
two hours after a 75 gram OGTT (World Health Organization, 1999).  
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Definition of the metabolic syndrome 
 
Diagnosis of the metabolic syndrome was defined according to the 2009 harmonized 
criteria, i.e. presence of at least three of the following conditions: central obesity (waist 
circumference ≥ 94 cm in men, ≥ 80 cm in women); elevated serum triglycerides  
(≥ 1.7 mmol/l), alternatively specific drug treatment for elevated triglycerides; reduced 
HDL cholesterol (HDL-C) (≤ 1.0 mmol/l in men, ≤ 1.3 mmol/l in women), 
alternatively specific drug treatment for reduced HDL-C; elevated blood pressure 
(systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85 mmHg), 
alternatively antihypertensive medication; elevated fasting glucose (≥ 5.6 mmol/l), 
alternatively diabetes medication (Alberti et al., 2009).  
 
Definition of NAFLD 
 
The NAFLD liver fat score, the NAFLD liver fat equation, (Kotronen et al., 2009) and 
the fatty liver index (FLI) (Bedogni et al., 2006) were used to define the presence of 
NAFLD in studies II and III.  
 
Kotronen’s score and equation (figures 5 and 6) are calculated using the following 
variables: presence of type 2 diabetes, presence of the metabolic syndrome, fS-insulin, 
fS-AST, and the ratio between fS-AST and fS-ALT. A score above the optimal cut-off 
point of -0.640 predicted NAFLD with a specificity of 71% and a sensitivity of 86% 
against proton-MRS in the original study. The correlation coefficient between liver fat 
percent as estimated by the NAFLD liver fat equation and liver fat percent according 
to proton-MRS was 0.70 (<0.001) (Kotronen et al., 2009).  
 
The FLI (figure 7) is calculated from the following variables: BMI, waist 
circumference, fS-triglycerides, and fS-GGT. An FLI > 60 predicted NAFLD with a 
specificity of 86% and a positive likelihood ratio of 4.3 compared to diagnosis with 
ultrasound in the original study (Bedogni et al., 2006).  
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Figure 5. The NAFLD liver fat score.  
 
Figure 6. The NAFLD liver fat equation. 
 
 
Figure 7. The Fatty Liver Index (FLI) 
 
Individuals with an alcohol intake greater than 20 grams per day, according to FFQ 
data, were excluded from the analysis. Those with current or previous liver disease 
were also excluded. To identify these individuals, a search for relevant ICD codes was 
performed in hospital discharge records, the national cancer register and the national 
mortality register. The following codes were basis for exclusion: ICD 8‒9; 070, 155, 
291, 303, 570, 571, 572, and 573; ICD 10: B15‒19, C22, F10, G62, K70‒77, and K86. 
Furthermore, individuals with medication potentially associated with secondary 
hepatic steatosis were also excluded (Chalasani et al., 2012). In Study II, morbid 
obesity (BMI ≥ 40 kg/m2) was basis for exclusion. Only individuals with all data 
necessary for calculating the NAFLD liver fat score were included in study II. A small 
number of individuals were excluded from study III due to implausible energy intake 
and missing information for the calculation of the FLI. The final number of subjects in 
study II and III were 1587 and 1611, respectively. 
 
NAFLD&liver&fat&score&=&32.89&+&1.18&*&metabolic&syndrome&(yes&=&1,&no&
=&0)&+&0.45&*&type&2&diabetes&(yes&=&2,&no&=&0)&+&0.15&*&fS3insulin&(mU/l)&
+&0.04&*&fS3AST&(U/l)&–&0.94&*&AST/ALT&
Liver&fat&(%)&=&10^(30.805&+&0.282&*&metabolic&syndrome&(yes&=&1,&no&=&
0)&+&0.708&*&type&2&diabetes&(yes&=&2,&no&=&0)&+&0.525&*&log&(fS3insulin&
(mU/l))&+&0.521&*&log&(fS3AST&(U/l))&–&0.454&*&log&(AST/ALT))&
FLI&=&(e^0.953&*&loge&(triglycerides)&+&0.139&*BMI&+&0.718&*&loge&(ggt)&+&
0.053&*&waist&circumference&3&15.745)&/&(1&+e^0.953&*&loge&
(triglycerides)&+&0.139&*&BMI&+&0.718&*&loge&(ggt)+&0.053&*&waist&
circumference&3&15.745)&*&100&
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Follow-up study 
 
1083 individuals without diagnosis of type 2 diabetes at the time of the first clinic visit 
were included in a follow-up study which took place in 2006‒08. During this visit, 
measurements were made of current weight, height, and blood pressure according to 
the protocols described above. Information on current medication was obtained from a 
questionnaire. An estimate of daily sodium intake (g/d) was once again obtained from 
FFQ data collected at the time of the clinic visit. Only individuals with available 
weight and height measurements for birth and ages 6 months, 2 years, and 11 years 
were included in study IV (n = 1036).  
 
4.4 Statistical methods 
 
Study I 
 
Clinical characteristics at birth and in adulthood were calculated as means with 
standard deviations and ranges, separately for men and women. Preliminary analysis of 
the data suggested a quadratic association between birth weight and RMR in men and a 
linear association in women. Accordingly, the analysis was stratified by sex. The 
associations were analysed using multiple linear regression, adjusting for sex, and 
either FFM, FM or both. The goodness-of-fit of models, with and without quadratic 
terms for birth weight, were analysed for both sexes using Akaike’s information 
criteria (AIC) (Akaike, 1998). AIC takes the number of fitted parameters into account 
making it suitable for comparing models with an unequal number of covariates. The 
smallest AIC (indicating the best model fit) were produced by quadratic models in men 
and linear models in women. All statistical analyses were performed using the R 
environment for statistical computing (R Team, 2007). 
 
Study II 
 
The study participants’ characteristics at birth, ages 2, 7, and 11 years, and adulthood, 
were calculated as means with SDs (or medians with interquartile ranges for skewed 
variables) and percentages. Measurements of weight, height, and BMI for each 
individual at all ages from birth to 11 years were converted to z scores (SD scores).  
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Z scores were obtained through interpolation as most measurements were not collected 
exactly on birthdays. Height and weight observations were available for 1435 
individuals for ages 0‒2 years and 7‒11 years. For ages 3, 4, 5, and 6 years, 1060, 728, 
822 and 1387 observations, respectively, were available for weight and 1023, 682, 795 
and 1386, respectively, were available for height. Residuals from linear regression 
analysis were used to measure how much the body size at a certain age differed from 
what would be predicted from size at an earlier age. This method is referred to as 
conditional growth. In other words, an individual with e.g. a negative value for 
conditional height growth but a positive value for conditional weight growth between 
ages 2 and 7 years would have gained less height but more weight during this interval 
than would have been expected from his or her previous body size and that of his or 
her peers of the same age. The intervals 0‒2, 2‒7, and 7‒11 years were used in the 
conditional analysis of changes in weight, height and BMI. In addition, an interval 
between 2 and 11 years was calculated for BMI.  
 
The NAFLD liver fat score was a converted to a dichotomous variable, with values 
greater than -0.640 defined as a positive NAFLD score. This variable was entered as 
the dependant variable into a series of logistic regression models. Each model included 
one childhood body size measurement or conditional growth variable as predictor 
variable, along with age, sex, and gestational age as covariates. When additionally 
adjusting for adult BMI, an interaction was found between sex and BMI. In an 
omnibus test of model coefficients, a model including birth weight, age, sex, 
gestational age, BMI, as well as an interaction term between sex and BMI, showed a 
significance level of 0.04 compared to a model without the interaction term (p for the 
interaction term 0.04). Accordingly, models adjusting for BMI were stratified by sex. 
Further adjustments for current and previous smoking status, daily energy intake, 
physical activity, and socioeconomic status in childhood and adulthood were explored 
but yielded no additional information compared to the sex-stratified BMI models. An 
additional model, including both BMI at age 2 years, and adult BMI, along with sex 
and age, was constructed to explore the combined effects of body size in infancy and 
BMI gain after age 11 years. Adjustment for gestational age was also explored but 
gave no additional information. BMI at 2 years was divided into tertiles while adult 
BMI was divided into groups reflecting the cut-off points for overweight and obesity 
(<25, 25‒30, >30).   
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The NAFLD liver fat equation was used to estimate liver fat percent for all 
participants. After log-transformation due to skewedness, the variable was entered as 
the dependant variable in a series of multiple linear regression models. The covariates 
included were the same as for the logistic models. A model adjusting for sex, age, 
gestational age, birth weight, and BMI was compared with a model also including an 
interaction term between sex and BMI. The significant F change between models was 
0.001 (p = 0.001 for the interaction term). Accordingly, the models controlling for 
adult BMI were stratified by sex. Additional adjustments for current and previous 
smoking status, daily energy intake, physical activity, and socioeconomic status in 
childhood and adulthood did not affect the results significantly. Based on the results 
from the regression models, change in the unlogged variable (regression coefficient) 
per unit predictor variable was calculated by (exp (regression coefficient) – 1) x 100. 
 
FLI was calculated for all participants but only applied for estimating the prevalence of 
NAFLD in the cohort, not in regression models. FLI was dichotomized at the cut-off 
point from the original study, i.e. at 60 and above. All statistical analyses were 
performed using SPSS version 21 (SPSS, Inc., Chicago, IL). 
 
Study III 
 
FLI and the NAFLD liver fat score were calculated for all participants. The scores 
were dichotomized as in study II and entered into logistic regression models with 
energy-adjusted quartiles of fructose intake as the predictor variables of interest. The 
residual method was applied for energy adjustment of all nutrient variables (Willett 
and Stampfer, 1986). Covariates were selected based on current literature. Four models 
were analysed for each dichotomous algorithm score outcome: “Model 0”, with no 
adjustments; model 1 with adjustments for sex, age and energy intake; model 2 with 
additional adjustments for smoking status and physical activity; and model 3, with 
further adjustments for alcohol, fiber, vitamin E, and total fat intake. The likelihood 
ratio test (LRT) was used to test each variable’s significance. An interaction test was 
performed between sex and the outcome variables. This revealed a non-significant 
interaction term (p > 0.05) and accordingly, analysis was combined for men and 
women. All analyses were performed using the R environment for statistical 
computing (R Team, 2013). 
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Study IV 
 
Z scores (SD scores) for weight and length/height measurements were obtained by 
applying the same methodology as in study II. Current size measures (represented by z 
scores) were regressed on previous size to obtain conditional size measures. 
Conditional relative birth weight was calculated by regressing birth weight on birth 
length. This measure represents how much an individual’s birth weight differs from 
what would have been expected based on his or her birth length and in relation to the 
other cohort members. Conditional relative weight represents current weight 
accounting for current height as well as previous weight and height. Conditional height 
represents current height taking previous weight and height into account. A negative 
conditional relative weight or negative conditional height represents a slower gain in 
relative weight or linear growth, respectively, than would have been expected based on 
the individual’s previous size and the growth of the other cohort participants. These 
conditional variables can be entered simultaneously into the same regression model, as 
they are statistically independent from each other. The following growth intervals were 
studied: birth to 6 months, 6 months to 2 years, 2 years to 11 years, and 11 years to 
adulthood. 
 
Multiple linear regression was used to study the associations between growth and adult 
systolic blood pressure at the first and second clinic visit, respectively. The predictive 
variables of primary interest were birth length (expressed as a z score), birth weight 
conditioned on birth length, and the conditional growth variables for relative weight 
gain and linear growth. These were entered into the regression model together with 
sex, age, childhood SES (ordinal, three levels), daily sodium intake in grams (log-
transformed due to skewedness), and antihypertensive medication (dichotomous, 
no/yes). The dependant variable was systolic blood pressure at either the first or the 
second clinic visit. In the latter cases, the analysis was also performed with systolic 
blood pressure at the first clinic visit as a covariate. This was done to see whether the 
birth size and conditional growth variables predicted current blood pressure 
independent of previous blood pressure. Additional adjustments for adult 
socioeconomic status, daily energy intake (available for both visits), current and 
previous smoking status (available only for the 2001‒04 visit), and leisure-time 
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physical activity (available only for the 2001‒04 visit), were explored but did not 
significantly affect the results.  
 
Dichotomous hypertension variables were created for each clinic visit based on the 
following three criteria: current use of antihypertensive medication, systolic blood 
pressure ≥ 140 mmHg, and diastolic blood pressure ≥ 90 mmHg. Individuals with at 
least one of these criteria present at the time of the clinical examinations were defined 
as hypertensive. The dichotomous variable was entered into a logistic regression model 
with the birth size and conditional growth variables as predictors of primary interest 
along with the same covariates as for the linear regression models, excluding current 
antihypertensive medication as this was part of the outcome variable. Systolic and 
diastolic blood pressure at the first clinic visit were added as covariates to the second 
visit model, after an omnibus test of model coefficients revealed a significance level of 
0.03 in a model including these variables compared to a model without them. Only 
individuals without hypertension, defined as above, at the first clinic visit were 
included in the second visit model (n = 311). All statistical analyses were performed 
using SPSS version 21 (SPSS, Inc., Chicago, IL). 
 
Study V 
 
Means and SDs were calculated for the participants’ characteristics in each cohort. A  
t-test was used for calculating 95% confidence intervals for the differences in means 
between cohorts. To explore the influence of birth year, dummy variables were created 
for each year of birth with 1943, the year with most births, as reference. Marital status 
was divided into three categories: married, unmarried, and unknown/other. The latter 
category represented widows and divorcees in the HBCS, whereas it represented those 
of unknown marital status in the Åland cohort. Dummy variables were created for the 
unmarried, and unknown/other categories with the married category as the reference. 
Birth weight was entered as the dependent variable into a multiple linear regression 
model with maternal age (centred at 28 years), the dummy variables for birth year and 
marital status, sex, and cohort of birth as model coefficients. Potential cohort specific 
associations were explored through interaction testing. Interaction terms were created 
between cohort of birth and each of the other covariates. For each covariate, a model 
including all covariates was compared to one additionally including the covariate of 
! 53!
interest’s interaction term. Only one interaction term was tested per model, with 
exception for the maternal marital status and birth year variables, respectively, which 
were analysed simultaneously. Significant F changes ≤ 0.05 were demonstrated for the 
marital status variables and maternal age and hence, the regression analysis was 
stratified by cohort. Furthermore, we created two sub-cohorts from the Åland material, 
representing those born in the regional capital of Mariehamn, and those born in rural 
areas. No sub-cohort specific effects were found in interaction testing, however. All 
statistical analyses were performed using SPSS version 21 (SPSS, Inc., Chicago, IL). 
 
Additional analyses performed after publication of the original articles 
 
The analyses included in study I were expanded upon to explore the associations 
between conditional growth and adult body composition applying the multiple linear 
regression methodology used in study IV. These analyses were performed using SPSS 
version 21 (SPSS, Inc., Chicago, IL). 
 
4.5 Ethical considerations 
 
The Helsinki Birth Cohort Study has been approved by the Ethics Committee of the 
Hospital District of Helsinki and Uusimaa. All participants in the clinical studies 
provided written informed consent. The study adheres to the declaration of Helsinki. 
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5 RESULTS 
  
5.1 Birth weight, body composition and resting metabolic rate 
 
The study population consisted of 408 men, and 488 women of mean ages 61.5 (SD 
2.7) and 61.6 (SD 3.1) years, respectively. Characteristics of the 896 study participants 
are found in table 2.  
 
Table 2. Characteristics of participants in Study I. 
 
 
Men 
(n = 408) 
Women 
(n = 488) 
  Mean SD Mean SD 
      
Birth characteristics     
 Birth weight (g) 3472 509 3347 478 
 Gestational age (days) 279.7 11.2 280.7 10.8 
Adult characteristics     
 Age (years) 61.5 2.7 61.6 3.1 
 Height (cm) 176.4 6.1 163.2 5.6 
 Weight (kg) 85.0 13.4 73.7 14.4 
 Body mass index (kg/m2) 27.3 4.0 27.7 5.2 
 Fat percentage (%) 23.4 5.9 33.9 7.1 
 Fat-free mass (kg) 64.5 7.8 47.9 6.0 
 Fat mass (kg) 20.4 8.0 25.8 10.0 
 Resting metabolic rate (kcal/24h) 1708 203 1380 143 
SD: Standard deviation.  
 
 
Birth weight was positively correlated with FFM (r = 0.27, p <0.001 for both sexes 
combined as well as separately for men and women). Birth weight was weakly 
correlated with FM in the combined analysis (r = 0.06, p <0.01) but in the stratified 
analysis only significant for men (r = 0.15, p < 0.001) and not in women (r = 0.06,  
p = 0.20). FFM was more strongly correlated to FM in men than in women (r = 0.61,  
p < 0.001 and r = 0.45, p <0.001, respectively). The correlation for both sexes 
combined, adjusted for sex, was r = 0.52 (p < 0.001). The correlation between FFM 
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and RMR was strong and significant (r = 0.88 for both sexes combined, r = 0.89 for 
men, and r = 0.86 for women, all p-values < 0.001). FM was also strongly and 
positively associated with RMR (r = 0.81 for both sexes combined, r = 0.78 for men, 
and r = 0.91 for women, all p-values < 0.001).  
 
A quadratic (u-shaped) association was found between age-adjusted RMR and birth 
weight among men (p < 0.001) whereas the association was linear and positive among 
women (p < 0.001). Additional adjustment for gestational age did not affect these 
trends. The association for men remained quadratic after further adjustment for FFM 
or FM, (p < 0.01, and p < 0.001, respectively). In women, adjustment for FM did not 
change the direction of the association (r = 0.25, p < 0.001). However, when adjusting 
for FFM the association was inverted (r = -0.12, p < 0.01). Further adjustment for 
gestational age did not significantly affect the associations. Simultaneous adjustment 
for age, FFM, and FM led to loss of significance at the 0.05 level for women (p = 0.16) 
but not among men (p = 0.05). According to Akaike’s information criteria of 
goodness-of-fit, all quadratic models were superior to the linear ones for men while the 
opposite was true for women. Figures 8‒11 shows the associations between birth 
weight and RMR separately for men and women with adjustments for only age, as well 
as for age and FFM. 
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Figure 8. The association between birth weight and age-adjusted RMR in men.  
 
 
RMR: Resting metabolic rate. 
 
 
Figure 9. The association between birth weight and age-adjusted RMR in women.  
 
 
RMR: Resting metabolic rate.  
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Figure 10. The association between birth weight and age- and FFM-adjusted RMR in 
men. 
 
RMR: Resting metabolic rate; FFM: Fat-free mass. 
 
 
Figure 11. The association between birth weight and age- and FFM-adjusted RMR in 
women. 
 
RMR: Resting metabolic rate; FFM: Fat-free mass. 
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5.1.1 Additional analysis applying methodology of study IV 
 
This analysis included 858 individuals and focused on the associations between adult 
body composition and conditional relative weight gain and linear growth. FFM was 
positively associated with all measurements of birth size and conditional growth, most 
strongly so with conditional relative weight gain between 11 years and adulthood 
where one SD of this variable was associated with a 4.1 kg (95% CI 3.9; 4.3) increase 
in FFM (table 3). The influence of relative weight gain during this period was even 
stronger on FM, where every SD of the conditional variable was associated with an 
estimated 8.6 kg (95% CI 8.4; 8.7) increase in FM (table 4). Interestingly though, 
body fat percent was only positively associated with conditional relative weight gain 
after age 2 years, whereas it was inversely associated with birth length and all linear 
growth measurements, except for the interval between ages 2 and 11 years. The most 
pronounced effects were found after age 11 years, where one SD of relative weight 
gain was associated with 5.5% (95% CI 5.3; 5.7) higher body fat percent and one SD 
of linear growth was associated with 0.7% (95% CI 0.5; 1.0) lower percent body fat 
(table 5).  
 
 
Table 3. Estimated change in FFM (kg) per unit predictor variable 
Predictor variable B 95% CI p 
(Constant) 82.6 78.4 86.7 <0.001 
Sex (0 = male, 1 = female) -17.2 -17.5 -16.8 <0.001 
Age (years) -0.01 -0.1 0.1 0.85 
Birth weight conditioned on birth length (SD) 0.5 0.3 0.6 <0.001 
Conditional relative weight gain 0 ‒ 6m (SD) 0.6 0.4 0.8 <0.001 
Conditional relative weight gain 6m ‒ 2y (SD) 0.8 0.6 1.0 <0.001 
Conditional relative weight gain 2 ‒ 11y (SD) 0.7 0.5 0.9 <0.001 
Conditional relative weight gain 11y ‒ adulthood (SD) 4.1 3.9 4.3 <0.001 
Birth length (SD) 1.7 1.6 1.9 <0.001 
Linear growth 0 ‒ 6m (SD) 1.5 1.3 1.6 <0.001 
Linear growth 6m ‒ 2y (SD) 1.7 1.5 1.9 <0.001 
Linear growth 2y ‒ 11y (SD) 2.0 1.9 2.2 <0.001 
Linear growth 11y ‒ adulthood (SD) 2.9 2.7 3.1 <0.001 
B: Regression coefficient; CI: Confidence interval; SD: Standard deviation; m: months; y: years. 
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Table 4. Estimated change in FM (kg) per unit predictor variable. 
Predictor variable B 95% CI p 
(Constant) 12.2 8.2 16.1 <0.001 
Sex (0 = male, 1 = female) 4.6 4.2 4.9 <0.001 
Age (years) 0.1 0.0 0.1 0.04 
Birth weight conditioned on birth length (SD) 0.7 0.5 0.8 <0.001 
Conditional relative weight gain 0 ‒ 6m (SD) 0.2 0.0 0.4 0.02 
Conditional relative weight gain 6m ‒ 2y (SD) 0.4 0.2 0.6 <0.001 
Conditional relative weight gain 2 ‒ 11y (SD) 2.0 1.8 2.2 <0.001 
Conditional relative weight gain 11y ‒ adulthood (SD) 8.6 8.4 8.7 <0.001 
Birth length (SD) 0.4 0.2 0.5 <0.001 
Linear growth 0 ‒ 6m (SD) 0.0 -0.2 0.2 0.83 
Linear growth 6m ‒ 2y (SD) 0.1 -0.1 0.3 0.28 
Linear growth 2y ‒ 11y (SD) 0.7 0.6 0.9 <0.001 
Linear growth 11y ‒ adulthood (SD) 0.2 0.1 0.4 0.01 
B: Regression coefficient; CI: Confidence interval; SD: Standard deviation; m: months; y: years. 
 
 
 
 
Table 5. Estimated change in body fat % per unit predictor variable. 
Predictor variable B 95% CI p 
(Constant) 8.6 3.6 13.5 0,001 
Sex (0 = male, 1 = female) 10.0 9.6 10.5 <0.001 
Age (years) 0.1 0.003 0.2 0.04 
Birth weight conditioned on birth length (SD) 0.2 -0.02 0.4 0.07 
Conditional relative weight gain 0 ‒ 6m (SD) -0.03 -0.3 0.2 0.78 
Conditional relative weight gain 6m ‒ 2y (SD) 0.1 -0.2 0.3 0.67 
Conditional relative weight gain 2 ‒ 11y (SD) 1.5 1.3 1.7 <0.001 
Conditional relative weight gain 11y ‒ adulthood (SD) 5.5 5.3 5.7 <0.001 
Birth length (SD) -0.3 -0.5 -0.1 0.002 
Linear growth 0 ‒ 6m (SD) -0.5 -0.7 -0.2 <0.001 
Linear growth 6m ‒ 2y (SD) -0.5 -0.8 -0.3 <0.001 
Linear growth 2y ‒ 11y (SD) -0.2 -0.4 0.1 0.15 
Linear growth 11y ‒ adulthood (SD) -0.7 -1.0 -0.5 <0.001 
B: Regression coefficient; CI: Confidence interval; SD: Standard deviation; m: months; y: years. 
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5.2 Childhood growth and NAFLD 
 
The mean age of the 646 male and 941 female study participants was 61.6 years (SD 
2.8 and 3.0, respectively). Mean liver fat percent was 4.2% (interquartile range 2.5; 
6.9) among men and 3.0% (interquartile range 1.9; 5.3) among women. NAFLD, as 
diagnosed by the NAFLD liver fat score, was present among 43.0% of the men and 
22.5% of the women. The prevalence was even higher when defining NAFLD 
according to FLI: 50.4% among men and 32.6% among women, respectively. The 
childhood and adult characteristics of the study population are described in tables 6 
and 7, respectively.  
 
Table 6. Childhood characteristics of participants in study II. 
 
 
Measurement 
Men (n=646) Women (n=941) 
Mean / % SD Mean / % SD 
     Birth     
     Length (cm) 50.6 2.0 50.0 1.8 
Weight (g) 3463 482 3358 463 
Ponderal index (kg/m3) 26.6 2.3 26.7 2.2 
Gestational age (days) 280 11 281 11 
     Age 2 years     
     Height (cm) 86.7 3.0 85.6 3.0 
Weight (kg) 12.4 1.1 11.9 1.1 
Body mass index (kg/m2) 16.7 1.2 16.4 1.2 
     Age 7 years     
     Height (cm) 121.0 4.7 120.1 4.7 
Weight (kg) 22.5 2.6 22.2 2.9 
Body mass index (kg/m2) 15.5 1.1 15.5 1.3 
     Age 11 years     
     Height (cm) 141.6 5.9 141.7 6.6 
Weight (kg) 33.8 4.5 34.3 5.7 
Body mass index (kg/m2) 16.8 1.5 17.0 1.9 
     SD: Standard deviation. 
 
 
No significant associations were demonstrated between birth anthropometrics and 
presence of NAFLD, according to the NAFLD liver score (figure 12). BMI and weight 
at 1 year of age, as well as weight at 2 years, adjusted for sex, age, and gestational age, 
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were all inversely associated with the dichotomous NAFLD outcome. After 
stratification by sex and additional adjustment for adult BMI, these inverse 
associations remained for both men and women. Additionally, in men, the model 
adjusted for adult BMI revealed several other inverse associations. For example, all 
measurements of BMI between ages 1 and 11 years were inversely associated with the 
dichotomous NAFLD outcome. 
 
In the combined models, with adjustments for sex, age, and gestational age, liver fat 
content was significantly inversely associated with weight at ages 1, 2 and 3 years, 
height at 2 and 5 years, and BMI at 3 years (figure 13). In women, a one SD increase 
of birth weight was associated with an estimated relative decrease of liver fat content 
by 5.4% (95% CI 1.5; 9.2) after additional adjustment for adult BMI, which 
corresponds to a relative decrease of 11.5 % (95% CI 3.2; 18.9, p 0.01) per kg birth 
weight. Except for birth weight in men, all measurements of weight and BMI were 
inversely associated with the outcome in both sexes, as well as height at age 7 years in 
women. In both figure 12 and 13, the mean values and 95% CIs at ages 3, 4, 5 and 6 
years are based on fewer observation than for the other years, as detailed in the 
statistics section.  
 
Conditional weight gain between birth and 2 years of age, adjusted for age, sex, and 
gestational age, was inversely associated with the dichotomous NAFLD outcome in 
both men and women (table 8). Conditional height gain was not significantly 
associated with NAFLD in either sex. In men, conditional BMI gain between birth and 
age 7 years, and conditional BMI gain between ages 2 and 11 years, were inversely 
associated with NAFLD. In women, conditional weight and BMI gain were inversely 
associated with liver fat content (table 9). In men, inverse associations were 
demonstrated for conditional weight and BMI gain between ages 2 and 7 years, and for 
conditional BMI gain between ages 2 and 11 years.  
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Table 7. Adult characteristics of participants in study II. 
 
 
Measurement 
Men (n=646) Women (n=941) 
Mean / 
% 
SD / 
Quartiles 
Mean /  
% 
SD / 
Quartiles 
     Age (years) 61.6 2.8 61.6 3.0 
Height (cm) 176.7 6.0 163.4 5.7 
Weight (kg) 85.2 12.7 73.1 12.4 
Body mass index (kg/m2) 27.3 3.7 27.4 4.4 
     Waist circumference (cm) 99.9 10.8 90.3 11.8 
Systolic blood pressure (mmHg) 146.4 19.7 144.1 21.0 
Diastolic blood pressure (mmHg) 90.2 10.7 87.6 10.2 
Fasting plasma glucose (mmol/l)1 5.7 5.4; 6.3 5.4 5.0; 5.8 
HDL cholesterol, mmol/l1 1.4 1.2; 1.6 1.7 1.4; 2.0 
Triglycerides, mmol/l1 1.3 1.0; 1.9 1.3 1.0; 1.7 
     High waist circumference (%)2 70.3  80.0  
Elevated blood pressure (%)3 86.7  82.5  
Elevated fasting glucose (%)4 62.1  61.1  
Reduced HDL-cholesterol (%)5 8.4  15.1  
Hypertriglyceridemia (%)6 32.3  26.2  
Presence of metabolic syndrome 
(%) 
56.7  45.9  
Presence of diabetes (%) 17.6  11.1  
     ALT (U/l)a 16.0 12.0; 22.0 13.0 9.0; 17.0 
AST (U/l) a 27.0 22.0; 33.0 23.0 19.0; 28.0 
Fasting insulin (pmol/l)1 9.2 6.1; 14.5 7.7 5.3; 11.4 
     NAFLD (liver fat score) (%)  
(%) 9(%= (%)(%) 
43.0  22.5  
NAFLD (FLI) ( ) 50.4  32.6  
Algorithm-based liver fat%1,7 4.2 2.5; 6.9 3.0 1.9; 5.3 
SD: Standard deviation; HDL: high density lipoprotein; ALT: Alanine aminotransferase; AST: 
Aspartate aminotransferase; NAFLD: Non-alcoholic fatty liver disease; FLI: Fatty Liver Index. 1Median 
values and interquartile ranges presented due to skewedness. 2‒62009 harmonized criteria for diagnosis 
of the metabolic syndrome 2Waist circumference ≥ 94 cm in men, ≥ 80 cm in women). 3Systolic blood 
pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85 mmHg and/or antihypertensive medication.  
4Fasting plasma glucose (≥ 5.6 mmol/l), alternatively diabetes medication 5Reduced high density 
lipoprotein cholesterol (HDL-C) (≤ 1.0 mmol/l in men, ≤ 1.3 mmol/l in women), alternatively drug 
treatment for reduced HDL-C 6Serum triglycerides (≥ 1.7 mmol/l), alternatively drug treatment for 
elevated triglycerides 7Liver fat percent estimated using the NAFLD liver fat equation. 
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Table 8. Odds ratio of a positive NAFLD score per SD of conditional growth variable. 
 
  
Growth 
0‒2 y 
Growth 
2‒7 y 
Growth 
7‒11 y 
Growth 
2‒11 y 
 
  OR 0.88 1.18 1.12 - 
 
Model 11 95%CI 0.78; 0.99 1.05; 1.33 0.99; 1.25 - 
 
  p 0.03 0.01 0.07 - 
 
        
 
  OR 0.77 0.89 1.00 - 
Weight 
Model 22, 
male 95%CI 0.63; 0.94 0.72; 1.09 0.82; 1.21 - 
 
  p 0.01 0.25 0.98 - 
 
        
 
  OR 0.79 1.14 0.91 - 
 
Model 22, 
female 95%CI 0.65; 0.96 0.94; 1.37 0.75; 1.10 - 
 
  p 0.02 0.18 0.31 - 
      
  
OR 0.91 1.08 1.09 - 
 
Model 11 95%CI 0.81; 1.03 0.96; 1.22 0.97; 1.23 - 
 
  p 0.14 0.19 0.15 - 
 
        
 
  OR 1.02 0.95 1.09 - 
Length/ 
height 
Model 22, 
male 95%CI 0.84; 1.25 0.78; 1.16 0.90; 1.32 - 
 
  p 0.83 0.61 0.38 - 
 
        
 
  OR 0.87 1.11 1.09 - 
 
Model 22, 
female 95%CI 0.72; 1.06 0.92; 1.33 0.90; 1.31 - 
 
  p 0.16 0.27 0.38 - 
      
 
Model 11 OR 0.91 1.14 1.10 1.17 
 
  95%CI 0.81; 1.03 1.01; 1.28 0.98; 1.24 1.04; 1.32 
 
  p 0.12 0.04 0.10 0.01 
   
    
 
  OR 0.69 0.81 0.92 0.80 
BMI 
Model 22, 
male 95%CI 0.56; 0.84 0.66; 0.99 0.75; 1.12 0.65; 0.98 
 
  p <0.001 0.04 0.40 0.03 
   
    
 
  OR 0.84 1.03 0.86 0.92 
 
Model 22, 
female 95%CI 0.70; 1.02 0.85; 1.24 0.71; 1.04 0.75; 1.11 
 
  p 0.08 0.77 0.12 0.37 
y: years; OR: Odds ratio; CI: Confidence interval; BMI: Body mass index. Significant associations 
italicized for clarity. 1Adjusted for sex, age, and gestational age; 2additionally adjusted for adult BMI. 
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Table 9. Relative % change in liver fat content (%) per SD of conditional growth variable. 
Measurement   
Growth 
0‒2 y 
Growth 
2‒7 y 
Growth 
7‒11 y 
Growth 
2‒11 y 
 
  % -3.3 2.1 3.7 - 
 
Model 11 95%CI -6.7; 0.1 -1.4; 5.9 0.1; 7.3 - 
 
  p 0.06 0.23 0.04 - 
 
        
 
  % -4.2 -6.6 -0.7 - 
Weight 
Model 22, 
male 95%CI -8.4; 0.2 -10.8; -2.1 -5.2; 3.9 - 
 
  p 0.06 0.004 0.75 - 
 
        
 
  % -6.8 -1.6 -2.2 - 
 
Model 22, 
female 95%CI -10.1; -3.1 -5.4; 2.3 -5.8; 1.6 - 
 
  p <0.001 0.33 0.25 - 
   -3.3 2.1 3.7  
  
% -3.3 0 0.3 - 
 
Model 11 95%CI -6.6; 0.1 -3.4; 3.6 -3.1; 3.9 - 
 
  p 0.06 0.99 0.85 - 
 
        
 
  % -1.0 -1.1 -1.5 - 
Length/ 
height 
Model 22, 
male 95%CI -5.4; 3.7 -5.5; 3.6 -5.8; 2.9 - 
 
  p 0.67 0.64 0.50 - 
 
        
 
  % -2.8 -2.3 0.2 - 
 
Model 22, 
female 95%CI -6.4; 0.9 -5.9; 1.4 -3.5; 4.0 - 
 
  p 0.14 0.22 0.93 - 
       
 
Model 11 % -2.0 2.9 4.0 4.9 
 
  95%CI -5.4; 1.5 -0.6; 6.5 0.4; 7.6 1.4. 8.7 
 
  p 0.25 0.11 0.03 0.01 
   
    
 
  % -5.5 -8.3 -1.5 -7.2 
BMI 
Model 22, 
male 95%CI -9.7; -1.2 -12.4. -4.1 -5.9; 3.1 -11.4; -2.8 
 
  p 0.01 <0.001 0.53 0.002 
   
    
 
  % -6.3 -2.0 -3.6 -4.1 
 
Model 22, 
female 95%CI -9.8; -2.7 -5.7; 1.8 -7.2; 0.1 -7.7; -0.3 
 
  p 0.001 0.30 0.06 0.04 
y: years; OR: Odds ratio; CI: Confidence interval; BMI: Body mass index. Significant associations 
italicized for clarity. 1Adjusted for sex, age, and gestational age; 2additionally adjusted for adult BMI. 
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Figure 14 and table 10 show the combined influence of BMI at age 2 years and adult 
BMI on the prevalence of NAFLD, defined by the NAFLD liver fat score. The model 
is adjusted for sex and age. The OR of a positive NAFLD score was 18.5  
(95% CI 10.1; 33.6) among those who belonged to the smallest BMI tertile at age 2 
years and subsequently were obese in adulthood compared to individuals of the same 
BMI tertile at age 2 years who were lean or normal weight as adults.   
 
Figure 14. Odds ratios and 95% confidence intervals for a positive NAFLD score 
according to BMI group in adulthood and BMI tertile at age 2 years. 
 
 
Table 10. Prevalence, odds ratios and 95% confidence intervals for a positive NAFLD 
score according to BMI group in adulthood and BMI tertile at age 2 years.  
  Adult BMI 
  < 25 25‒30 >30 
 
BMI 
2y 
 
 OR 95% CI %1 OR 95% CI % 1 OR 95% CI % 1 
<16 1.0 - 12.1 3.7 2.2; 6.1 32.4 18.5 10.1; 33.6 67.6 
16‒17 0.7 0.4; 1.4 9.4 2.6 1.6; 4.4 28.6 13.2 7.5; 23.2 60.8 
>17 0.3 0.1; 0.8 3.5 2.5 1.5; 4.2 29.3 8.8 5.0; 15.2 51.8 
BMI: Body mass index: 1Percentages represent the proportion of individuals within the BMI group with 
NAFLD diagnosis according to the NAFLD liver fat score.  
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5.3 Fructose intake and NAFLD 
 
Table 11 shows the characteristics of the participants in study III, according to 
quartiles of fructose intake. Prevalence of NAFLD, according to FLI, was 44%. The 
corresponding number for the NAFLD liver fat score was 32%. Compared to 
individuals belonging to the lowest quartile of fructose intake, those belonging to the 
highest quartile were more likely to be women than men, less likely to be smokers or 
physically inactive, and had higher educational attainment.  
 
Fructose intake was inversely associated with NAFLD diagnosis according to both 
algorithm scores, when adjusting for age, sex, and energy intake (model 1) (table 12). 
After further adjustments for leisure-time physical activity and smoking (model 2), as 
well as total intake of fat, fiber, alcohol, and vitamin E (model 3), the inverse 
association only remained for the FLI. The OR for NAFLD according to FLI in the 
fully adjusted model was 0.68 (95% CI 0.47; 0.97, p for trend <0.05) for individuals 
belonging to the quartile with the highest intake of fructose compared to the lowest 
quartile.  
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5.4 Childhood growth and hypertension: amplification with age 
 
Childhood and adult characteristics of the 1036 study participants are found in tables 
13 and 14. The proportion of participants using antihypertensive medication was 
30.3% and 42.2%, at the first and second clinic visit, respectively. 61.9% and 62.8% 
had blood pressure values within the hypertensive range, respectively.  
 
Systolic blood pressure at the first clinic visit was inversely associated with birth 
length and birth weight conditioned on birth length. For every SD increase in these 
variables, systolic blood pressure decreased 1.1 mmHg (95% CI 0; 2.2) and 1.4 mmHg 
(95% CI 0.3; 2.5), respectively (table 15). Conversely, a positive association was 
demonstrated between relative weight gain after age 11 years. One SD of this 
conditional variable was associated with 3.8 mmHg (95% CI 2.2; 5.1) higher systolic 
blood pressure. Several inverse associations were found between systolic blood 
pressure at the time of the second clinic visit and the childhood conditional growth 
variables (table 15). For example, both conditional relative weight gain and linear 
growth between ages 2 and 11 years were inversely associated with the outcome, both 
before and after adjustment for systolic blood pressure at the time of the first clinic 
visit. Relative weight gain after age 11 years stayed positively associated with the 
outcome in all models, albeit attenuated to 1.1 mmHg (95% CI 0.1; 2.1, p = 0.04) per 
SD of the conditional variable in the fully adjusted model. Birth length and birth 
weight conditioned on birth length were both associated with an odds ratio of 0.85 
(95% CIs 0.75; 0.98 and 0.74; 0.98, respectively, p = 0.02 for both associations) for 
hypertension at the first clinic visit, per SD of conditional variable (table 15). One SD 
of conditional relative weight gain after age 11 years was associated with an odds ratio 
of 1.79 (95% CI 1.51, 2.11, p <0.001) for hypertension. At the time of the second 
clinic visit, an inverse association was demonstrated for linear growth between ages 2 
and 11 years with an odds ratio of 0.61 (95% CI 0.4; 0.81, p = 0.001) for hypertension 
per SD of the conditional variable (table 15). 
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Table 13. Childhood characteristics of participants in study IV. 
 Female (n=574) Male (n=462) 
 Mean/ 
Median/% 
 
SD/ IQR 
Mean/ 
Median/% 
 
SD /IQR 
     
Birth weight (g) 3365 459 3481 487 
Birth length (cm) 50.1 1.8 50.7 2.0 
     
Weight 6 months (kg) 7.4 0.8 7.9 0.8 
Length 6 months (cm) 66.3 2.2 67.9 2.3 
     
Weight 2 years (kg) 12.0 1.1 12.5 1.1 
Height 2 years (cm) 85.8 3.0 86.8 3.0 
     
Weight 11 years (kg) 34.4 5.6 33.7 4.4 
Height 11 years (cm) 141.7 6.4 141.7 5.7 
   
Childhood SES  
(low / medium / high, %) 
15.1 / 22.4 / 62.5 18.7 / 22.3 / 59.0 
SD: Standard deviation. IQR: Interquartile range; SES: Socioeconomic status. 
 
Table 14. Adult characteristics of participants in study IV. 
 Female (n=574) Male (n=462) 
 Mean/ 
Median/% 
 
SD/ IQR 
Mean/ 
Median/% 
 
SD /IQR 
     
First clinic visit (2001‒04)     
Age (years) 61.5 3.0 61.4 2.7 
Weight (kg) 72.3 12.5 84.6 11.9 
Height (cm) 163.5 5.7 176.9 5.9 
Daily sodium intake (g)1 3.0 2.4; 3.6 3.6 2.9; 4.5 
Systolic blood pressure (mmHg) 141.8 20.2 144.6 18.4 
Diastolic blood pressure (mmHg) 86.9 10.0 89.8 9.9 
     
Second clinic visit (2006‒08)     
Age (years) 66.6 2.9 66.2 2.7 
Weight (kg) 72.0 13.5 83.2 12.0 
Height (cm) 162.8 5.7 176.4 6.0 
Daily sodium intake (g)1 3.0 2.5; 3.6 3.7 2.9; 4.5 
Systolic blood pressure (mmHg) 143.5 20 146.2 19.9 
Diastolic blood pressure (mmHg) 89.4 11.1 90.4 10.9 
SD: Standard deviation. IQR: Interquartile range; SES: Socioeconomic status.  
1Median and interquartile range 
Ta
bl
e 
15
. E
st
im
at
ed
 c
ha
ng
e 
in
 sy
st
ol
ic
 b
lo
od
 p
re
ss
ur
e 
pe
r u
ni
t p
re
di
ct
or
 v
ar
ia
bl
e.
  
   
C
lin
ic
 v
is
it 
1 
 
 
C
lin
ic
 v
is
it 
2,
  
M
od
el
 1
 
 
C
lin
ic
 v
is
it 
2,
 
M
od
el
 2
 
Pr
ed
ic
to
r 
va
ri
ab
le
 
B
 
95
%
 C
I 
 
B
 
95
%
 C
I 
 
B
 
95
%
 C
I 
 
 
 
 
 
 
 
 
 
(C
on
st
an
t) 
84
.5
 
59
.3
 
10
9.
7 
 
96
.2
 
66
.5
 
12
5.
9 
 
58
.9
 
34
.0
 
83
.9
 
Se
x 
(0
 =
 m
al
e,
 1
 =
 fe
m
al
e)
 
-3
.8
 
-6
.1
 
-1
.4
 
 
-4
.1
 
-6
.6
 
-1
.5
 
 
-1
.8
 
-3
.9
 
0.
3 
A
ge
 (y
ea
rs
) 
1.
0 
0.
6 
1.
4 
 
0.
7 
0.
3 
1.
1 
 
0.
0 
-0
.3
 
0.
4 
B
irt
h 
w
ei
gh
t c
on
di
tio
ne
d 
on
 b
irt
h 
le
ng
th
 (S
D
) 
-1
.1
 
-2
.2
 
0.
0 
 
-0
.7
 
-1
.9
 
0.
5 
 
0.
0 
-1
.0
 
1.
0 
C
on
di
tio
na
l r
el
at
iv
e 
w
ei
gh
t g
ai
n 
0 
‒ 
6m
 (S
D
) 
-0
.6
 
-1
.7
 
0.
5 
 
0.
2 
-1
.0
 
1.
4 
 
0.
6 
-0
.4
 
1.
6 
C
on
di
tio
na
l r
el
at
iv
e 
w
ei
gh
t g
ai
n 
6m
 ‒
 2
y 
(S
D
) 
-0
.8
 
-1
.9
 
0.
3 
 
-1
.2
 
-2
.4
 
-0
.1
 
 
-0
.7
 
-1
.7
 
0.
2 
C
on
di
tio
na
l r
el
at
iv
e 
w
ei
gh
t g
ai
n 
2 
‒ 
11
y 
(S
D
) 
0.
0 
-1
.2
 
1.
2 
 
-1
.2
 
-2
.5
 
0.
1 
 
-1
.2
 
-2
.2
 
-0
.1
 
C
on
di
tio
na
l r
el
at
iv
e 
w
ei
gh
t g
ai
n 
11
y 
‒ 
ad
ul
th
oo
d 
(S
D
) 
3.
8 
2.
5 
5.
1 
 
3.
2 
2.
0 
4.
4 
 
1.
1 
0.
1 
2.
1 
B
irt
h 
le
ng
th
 (S
D
) 
-1
.4
 
-2
.5
 
-0
.3
 
 
-1
.7
 
-3
.0
 
-0
.5
 
 
-0
.7
 
-1
.8
 
0.
3 
Li
ne
ar
 g
ro
w
th
 0
 ‒
 6
m
 (S
D
) 
-0
.8
 
-1
.9
 
0.
3 
 
-1
.4
 
-2
.6
 
-0
.3
 
 
-1
.0
 
-2
.0
 
0.
0 
Li
ne
ar
 g
ro
w
th
 6
m
 ‒
 2
y 
(S
D
) 
-1
.1
 
-2
.2
 
0.
0 
 
-0
.1
 
-1
.3
 
1.
2 
 
0.
6 
-0
.4
 
1.
6 
Li
ne
ar
 g
ro
w
th
 2
y 
‒ 
11
y 
(S
D
) 
-0
.6
 
-1
.8
 
0.
6 
 
-1
.7
 
-3
.0
 
-0
.4
 
 
-1
.3
 
-2
.4
 
-0
.3
 
Li
ne
ar
 g
ro
w
th
 1
1y
 ‒
 a
du
lth
oo
d 
(S
D
) 
-0
.8
 
-1
.9
 
0.
3 
 
-1
.1
 
-2
.3
 
0.
1 
 
-0
.5
 
-1
.5
 
0.
5 
A
nt
ih
yp
er
te
ns
iv
e 
m
ed
ic
at
io
n 
(0
 =
 n
o,
 1
 =
 y
es
) 
6.
2 
3.
7 
8.
7 
 
-0
.3
 
-2
.7
 
2.
2 
 
0.
6 
-1
.4
 
2.
6 
D
ai
ly
 so
di
um
 in
ta
ke
 (g
) (
lo
ga
rit
hm
iz
ed
) 
-3
.9
 
-7
.1
 
-0
.6
 
 
-3
.3
 
-7
.1
 
0.
4 
 
-2
.3
 
-5
.4
 
0.
8 
C
hi
ld
ho
od
 S
ES
 (l
ow
, m
ed
iu
m
, h
ig
h)
 
1.
8 
0.
3 
3.
3 
 
1.
7 
0.
1 
3.
3 
 
0.
4 
-0
.9
 
1.
7 
Ti
m
e 
be
tw
ee
n 
vi
si
ts
 (i
n 
ye
ar
s)
 
 
 
 
 
0.
8 
-0
.6
 
2.
3 
 
0.
6 
-0
.6
 
1.
8 
10
 m
m
H
g 
of
 sy
st
ol
ic
 B
P 
at
 fi
rs
t c
lin
ic
 v
is
it 
 
 
 
 
 
 
 
 
5.
9 
5.
3 
6.
4 
C
I: 
C
on
fid
en
ce
 in
te
rv
al
, S
D
: S
ta
nd
ar
d 
de
vi
at
io
n.
 S
ES
: S
oc
io
ec
on
om
ic
 st
at
us
. B
P:
 B
lo
od
 p
re
ss
ur
e.
 A
ll 
pr
ed
ic
to
r v
ar
ia
bl
es
 in
 e
ac
h 
m
od
el
 e
nt
er
ed
 si
m
ul
ta
ne
ou
sl
y.
  
A
ss
oc
ia
tio
ns
 w
ith
 si
gn
ifi
ca
nc
e 
le
ve
l <
0.
05
 b
ol
de
d 
fo
r c
la
rit
y.
 
 
 
73#
Ta
bl
e 
16
. O
dd
s r
at
io
 fo
r h
yp
er
te
ns
io
n 
pe
r u
ni
t p
re
di
ct
or
 v
ar
ia
bl
e.
  
 
                            
O
R
: O
dd
s r
at
io
; C
I: 
C
on
fid
en
ce
 in
te
rv
al
; m
: m
on
th
s;
 y
: y
ea
rs
; B
P:
 b
lo
od
 p
re
ss
ur
e.
 A
ss
oc
ia
tio
ns
 w
ith
 si
gn
ifi
ca
nc
e 
le
ve
l <
0.
05
 b
ol
de
d 
fo
r c
la
rit
y.
 
 
C
lin
ic
 v
is
it 
1 
 
C
lin
ic
 v
is
it 
2 
 
Pr
ed
ic
to
r 
va
ri
ab
le
 
O
R
 
95
%
 C
I 
 
O
R
 
95
%
 C
I 
C
on
st
an
t 
0.
04
 
 
 
 
0.
01
 
  
  
Se
x 
(0
 =
 m
al
e,
 1
 =
 fe
m
al
e)
 
0.
74
 
0.
56
 
0.
98
 
 
1.
28
 
0.
76
 
2.
18
 
A
ge
 (y
ea
rs
) 
1.
07
 
1.
02
 
1.
12
 
 
0.
97
 
0.
88
 
1.
07
 
B
irt
h 
w
ei
gh
t c
on
di
tio
ne
d 
on
 b
irt
h 
le
ng
th
 (S
D
) 
0.
85
 
0.
75
 
0.
98
 
 
1.
08
 
0.
85
 
1.
38
 
C
on
di
tio
na
l r
el
at
iv
e 
w
ei
gh
t g
ai
n 
0 
‒ 
6m
 (S
D
) 
0.
95
 
0.
83
 
1.
08
 
 
1.
11
 
0.
86
 
1.
42
 
C
on
di
tio
na
l r
el
at
iv
e 
w
ei
gh
t g
ai
n 
6m
 ‒
 2
y 
(S
D
) 
0.
92
 
0.
81
 
1.
04
 
 
1.
10
 
0.
87
 
1.
39
 
C
on
di
tio
na
l r
el
at
iv
e 
w
ei
gh
t g
ai
n 
2 
‒ 
11
y 
(S
D
) 
0.
94
 
0.
82
 
1.
09
 
 
0.
94
 
0.
72
 
1.
22
 
C
on
di
tio
na
l r
el
at
iv
e 
w
ei
gh
t g
ai
n 
11
y 
‒ 
ad
ul
th
oo
d 
(S
D
) 
1.
79
 
1.
51
 
2.
11
 
 
0.
95
 
0.
67
 
1.
36
 
B
irt
h 
le
ng
th
 (S
D
) 
0.
85
 
0.
74
 
0.
98
 
 
1.
03
 
0.
79
 
1.
33
 
Li
ne
ar
 g
ro
w
th
 0
 ‒
 6
m
 (S
D
) 
0.
88
 
0.
77
 
1.
00
 
 
0.
94
 
0.
72
 
1.
23
 
Li
ne
ar
 g
ro
w
th
 6
m
 ‒
 2
y 
(S
D
) 
0.
89
 
0.
78
 
1.
01
 
 
0.
82
 
0.
64
 
1.
05
 
Li
ne
ar
 g
ro
w
th
 2
y 
‒ 
11
y 
(S
D
) 
1.
02
 
0.
89
 
1.
18
 
 
0.
61
 
0.
45
 
0.
81
 
Li
ne
ar
 g
ro
w
th
 1
1y
 ‒
 a
du
lth
oo
d 
(S
D
) 
0.
96
 
0.
84
 
1.
10
 
 
0.
90
 
0.
71
 
1.
13
 
C
hi
ld
ho
od
 S
ES
 (l
ow
, m
ed
iu
m
, h
ig
h)
 
1.
14
 
0.
96
 
1.
35
 
 
1.
22
 
0.
89
 
1.
66
 
D
ai
ly
 so
di
um
 in
ta
ke
 (g
) (
lo
ga
rit
hm
iz
ed
) 
0.
92
 
0.
83
 
1.
02
 
 
1.
01
 
0.
83
 
1.
24
 
D
ia
st
ol
ic
 B
P 
at
 fi
rs
t v
is
it 
(m
m
H
g)
 
 
 
 
 
1.
04
 
1.
00
 
1.
10
 
Sy
st
ol
ic
 B
P 
at
 fi
rs
t v
is
it 
(m
m
H
g)
 
 
 
 
 
1.
02
 
0.
99
 
1.
05
 
Ti
m
e 
be
tw
ee
n 
vi
si
ts
 (y
ea
rs
) 
 
 
 
 
1.
12
 
0.
85
 
1.
49
 
74##
! 75!
5.5 Regional differences in birth size 
 
Characteristics of the study participants are described in table 17. The Helsinki Birth 
Cohort Study subjects born 1937‒44 comprised 11808 individuals. The corresponding 
number for the Åland cohort was 1697 births. Mean birth weight on the Åland Islands 
was 3499 grams, 87 grams (95% CI 62; 111) more than for those born in Helsinki. 
Mean birth length was 50.7 cm, 0.4 cm (0.3; 0.5) more than in Helsinki. Ålandic 
mothers were on average 6 months (95% CI 3.6; 9.6 months) younger than their 
Helsinki peers with a mean age of 27.9 years (SD 5.9). Babies born to unmarried 
mothers on the Åland Islands were 291 grams (95% CI 123; 459) lighter than those 
born to married mothers, on average. The corresponding average weight difference in 
Helsinki was 111 grams (95% CI 79; 153). Table 18 shows the associations between 
predictor variables and birth weight for both cohorts combined as well as stratified. 
 
 
 
Table 17. Characteristics of the participants in study V.  
 Helsinki 
n = 11808 
Åland 
n = 1697 
 Mean (SD) / % range Mean (SD) / % range 
 
Maternal 
characteristics 
    
Maternal age (years) 28.5 (5.5) 15‒48 27.9 (5.9) 15‒45 
Marital status (%) 
- Married 
- Unmarried 
- Unknown/other 
 
95.1 
4.4 
0.4 
  
94.7 
2.2 
3.1 
 
     
Offspring 
characteristics 
    
Female (%) 47.6  48.3  
Birth weight (g) 3412 (479) 1260‒5640 3499 (508) 1100‒5500 
Birth length (cm) 50.3 (1.9) 41‒59 50.7 (2.1) 34‒59 
SD: Standard deviation 
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6 DISCUSSION 
  
6.1 Birth weight, body composition and resting metabolic rate 
 
Birth weight was positively associated with fat-free mass (FFM) in both men and 
women and with fat mass (FM) in men. The most pronounced association between 
childhood growth and adult body composition was found for relative weight gain 
between age 11 years and adulthood. One SD of this conditional variable was 
associated with an estimated 4.1 kg (95% CI 3.9; 4.3) increase of FFM, 8.6 kg (95% 
CI 8.4; 8.7) increase of FM and 5.5 % (95% CI 5.3; 5.7) increase of body fat percent. 
Birth length and all measurements of linear growth, except for the interval between 2 
and 11 years, were inversely associated with body fat percent. In men, the association 
between birth weight and resting metabolic rate (RMR) was quadratic, after adjustment 
for age, FFM and FM. In women, an inverse association was found between birth 
weight and RMR, after adjustment for age and FFM. This association lost significance 
after additional adjustment for FM. 
 
A small number of previous studies have demonstrated an inverse association between 
birth weight and adult RMR (Sipola-Leppänen et al., 2011, Kensara et al., 2006, 
Eriksson et al., 2002, Weyer et al., 2000). In the studies by Eriksson et al and Sipola-
Leppänen et al, RMR, expressed per unit of FFM, was higher in individuals with low 
birth weight, indicating that these have more metabolically active FFM. In healthy 
individuals, body mass does not influence specific internal organ metabolism (Later et 
al., 2008) suggesting that the relatively higher metabolic activity per unit FFM, 
described in the above studies, might be specific to the muscle mass compartment of 
the FFM. On the other hand, these findings could also be explained by a smaller 
amount of total muscle mass in individuals with low birth weight, leading to a larger 
relative contribution to RMR from more metabolically active compartments of FFM 
(i.e. internal organs) (Heymsfield et al., 2002).  
 
In the present study, the associations between birth weight and RMR remained 
significant despite adjustment for FFM in both sexes, as well as after additional 
adjustment for FM in men, suggesting that the early life origins of resting metabolism 
are not solely mediated by adult body composition. A low birth weight is associated 
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with elevated plasma cortisol (Phillips et al., 2000) which might accordingly mediate 
the association between birth weight and RMR. Additionally, low birth weight has 
been linked to increased sympathetic tone (Ijzerman et al., 2003) which in turn has 
been linked to increased resting metabolism in non-obese, healthy adults (Monroe et 
al., 2001). Two small experimental studies (n = 9 and n = 8, respectively) in humans 
have demonstrated increased energy expenditure after administration of cortisol, and 
corticotropin-releasing hormone (CRH), respectively (Brillon et al., 1995, Smith et al., 
2001). Although no previous study has demonstrated sex-specific differences in the 
associations between birth weight and resting metabolism, some studies have 
demonstrated that the developmental programming of the autonomic nervous system 
and the HPAA differs between men and women (Kajantie and Räikkönen, 2010). In 
their review, Kajantie and Räikkönen conclude that early developmental factors seem 
to be more strongly associated with autonomic nervous system reactivity in women, 
and with reactivity in peripheral vasculature, and potentially the HPAA, in men. This 
might in underlie our findings.  
 
6.2 Childhood growth and NAFLD 
 
Non-alcoholic fatty liver disease is the most prevalent cause of chronic liver disease in 
the Western world. It is closely associated with obesity, type 2 diabetes and the 
metabolic syndrome as well as with an increased overall mortality, due to liver-related 
disease and CVD (Musso et al., 2011). To our knowledge, this study represents the 
first study of the developmental origins of NAFLD in a large epidemiological setting.  
 
NAFLD was defined according to the NAFLD liver fat score (Kotronen et al., 2009), 
an algorithm score including five readily available variables. NAFLD, which was 
present in 43% of the male and 20.5% of the female subjects, was inversely associated 
with several measurements of childhood body size between birth and age 11 years. 
Similar results were seen for liver fat content, calculated using the NAFLD liver fat 
equation. The most pronounced association with adult NAFLD was seen for 
individuals who were lean at 2 years of age and subsequently obese as adults. These 
had an OR of 18.5 (95% CI 10.1; 33.6) for NAFLD, compared to individuals who 
remained lean or normal weight in adulthood. 
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Previous studies featuring the current study population have revealed inverse 
associations between various measurements of childhood body size and the metabolic 
syndrome in both normal weight and obese individuals (Salonen et al., 2009a, Salonen 
et al., 2009b). Accordingly, our findings are expected, considering that NAFLD is a 
feature of the metabolic syndrome and that the metabolic syndrome, or features 
thereof, are included in the algorithm tests used to define NAFLD. The metabolic 
syndrome was present for 56.7% of the male participants, and for 49.5% of the female. 
This corresponds to findings from the 2007 Fin-D2D survey, featuring Finnish men 
and women aged 45‒74 years, where the prevalence was 60.1% in men and 54.3% in 
women (Pajunen et al., 2011).  
 
Three studies assessing the influence of childhood growth on later risk of developing 
NAFLD have recently been published, one from the Avon Longitudinal Study of 
Parents and Children (ALSPAC) study (Anderson et al., 2014), one from the Western 
Australian (Raine) cohort (Ayonrinde et al., 2015) and one from the PROGRAM study 
(Breij et al., 2014). In contrast to our findings, these studies demonstrated positive 
associations between various phases of early growth and NAFLD, as diagnosed by 
ultrasound or FLI. Importantly though, the participants of these studies were much 
younger than those included in the present study, with mean ages of 17.8, 17 and 20.9 
years, respectively. Additionally, mean BMI at age 10.5‒11.49 in the ALSPAC study 
was 18.3 kg/m2 (SD 3.1) and 18.55 kg/m2 (SD 3.16) in the Raine study compared to 
16.9 kg/m2 (SD 1.7) in the HBCS. These BMI values refer to all ALSPAC and Raine 
study participants, not only those included in the NAFLD analyses (Warrington et al., 
2013). In the HBCS, childhood obesity was very rare. Only 3 boys and 30 girls in 
study II had BMIs at age 11 years corresponding to values ≥ 25 kg/m2 (age specific 
cut-off points ≥ 20.55 kg/m2 and ≥ 20.74 kg/m2, respectively) (Cole et al., 2000). This 
most likely explains the inconsistencies between our findings and those of Andersson, 
Ayonrinde and Breij. Our main finding, that the highest prevalence of NAFLD was 
seen in those who were lean at age 2 years and subsequently obese in adulthood, 
supports the hypothesis that those who developed obesity and NAFLD in our cohort 
did so after age 11 years. In this group, the prevalence of NAFLD was 67.6% 
compared to only 3.5% among those who belonged to the largest BMI tertile at age 2 
years and were lean or normal weight as adults. 
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The underlying mechanisms of the association between early growth and later NAFLD 
are poorly understood. Animal studies have demonstrated that both maternal 
undernutrition and overnutrition, as well as maternal obesity, are associated with 
NAFLD in the offspring (Hyatt et al., 2011, Bruce et al., 2009, Mouralidarane et al., 
2013, Oben et al., 2010, Pruis et al., 2014). The influence of maternal obesity has also 
been demonstrated in human studies. Hepatic intracellular fat content, measured by 
MRI, was positively associated with maternal BMI in two studies of newborn infants 
(Brumbaugh et al., 2013, Modi et al., 2011). In a recent study from the epidemiological 
part of the 1934‒44 HBCS (n = 13345), a higher maternal BMI during late pregnancy 
was associated with several disease outcomes in adulthood, most strongly so with type 
2 diabetes and cardiovascular disease. (Eriksson et al., 2014). NAFLD, however, was 
not among the outcomes studied.  
 
6.3 Fructose intake and NAFLD 
 
A high dietary intake of fructose has been suggested to contribute to the development 
of NAFLD (Vos and Lavine, 2013). In our study, however, NAFLD was least 
prevalent in the highest quartile of fructose intake. In a model controlling for age, sex, 
smoking status, physical activity, and various nutrients, the odds ratio for FLI-defined 
NAFLD was 0.68 (95% CI 0.47; 0.97) in the highest quartile of fructose intake 
compared to the lowest.  
 
Median fructose intake in the HBCS was 20 g/d. In comparison, fructose doses 
administered in the animal and human feeding studies that have linked fructose to 
NAFLD typically vary between 60 and 220 g/d. In our study, only 45 individuals had 
fructose intakes exceeding 60 g/d. This most likely explains the inconsistencies 
between our results and those of previous studies. Indeed, the hypothesis of an 
association between fructose and NAFLD has been called into question, as most 
previous studies have featured extreme levels of fructose exposure (Chiu et al., 2014). 
When comparing an isocaloric high-fat diet to an isocaloric high-carbohydrate, the 
prior increased liver fat content and insulin levels more than the latter (Pietinen et al., 
2010). Another study, featuring healthy young men, showed that overfeeding with fat 
increased liver fat more than overfeeding with fructose (Sobrecases et al., 2010). The 
increase of intrahepatocellular lipids and liver enzymes seen in hypercaloric studies 
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might be confounded by, or be a result of, excessive energy intake rather than to the 
effects of fructose intake (Chiu et al., 2014, Chung et al., 2014).   
 
The potential role of fructose in the pathogenesis of NAFLD is further influenced by 
its dietary source. A strong association between soft-drink consumption and NAFLD 
has been demonstrated in previous studies (Assy et al., 2008, Abid et al., 2009). In 
Finland, the main sources of fructose are table sugar, soft drinks and fruit. Although 
fructose intake was not separated by source in our study, the proportion of study 
participants who reported intake of fruit (not including fruit juices) was 54‒80% 
compared to 0‒8% for soft drinks (not including artificially sweetened soft drinks). 
Accordingly, it is possible that the potentially harmful effects of soft drink intake have 
been overshadowed by the beneficial effects of fruit intake, in our study.  
 
6.4 Childhood growth and hypertension: amplification with age  
 
Although several previous studies have explored the associations between childhood 
growth and adult hypertension, none have, to our knowledge, assessed whether these 
associations change over time in adult life. In our longitudinal study of 1036 men and 
women, examined at mean ages 61.5 and 66.4 years, respectively, we found that 
several measurements of childhood growth before age 11 years were inversely 
associated with adult systolic blood pressure at mean age 66.4 years. Some of these 
associations remained significant, despite adjustment for systolic blood pressure at 
mean age 61.5 years. Additionally, the presence of hypertension at mean age 66.4 
years was inversely associated with linear growth between ages 2 and 11 years. In 
contrast to this, the only significant associations found with hypertension and systolic 
blood pressure at mean age 61.5 years were for birth measurements. Conditional 
relative weight gain between age 11 years and adulthood was positively associated 
with the presence of hypertension at mean age 61.5 years, as well as with systolic 
blood pressure at both clinic visits. 
 
Contrary to our findings, previous studies have demonstrated positive associations 
between early childhood growth and later blood pressure. Importantly though, stronger 
associations were found for later rather than earlier growth. In a publication from the 
ALSPAC study, growth after age 17 months was more strongly associated with 
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systolic blood pressure at age 10 years than growth from birth until 17 months (Jones 
et al., 2012). A study from Chiolero et al demonstrated that systolic blood pressure at 
age 15.5 years was more strongly associated with weight change between ages 12.5–
15.5 years than with weight change between ages 1 and 12.5 years indicating that 
blood pressure is most responsive to recent, rather than earlier changes in weight 
(Chiolero et al., 2012). In a Danish study (n = 1284) of men born 1936‒1970, adult 
systolic blood pressure was more strongly affected by changes in relative body size 
after age 11 years, compared to changes in earlier childhood (Gamborg et al., 2009). 
 
Whereas previous studies have primarily focused on young individuals, the HBCS 
consists of men and women born 1934‒44 who were 56‒70 years old at the time of the 
first clinical examination in 2001-04. Childhood obesity was very rare among 
participants in our study. Compared to current Finnish growth standards, the study 
participants were shorter than current mean attained adult height, 3.8 cm for men and 
3.7 cm for women and additionally, shorter and leaner during childhood (Saari et al., 
2011). Taking this into account, it is likely that a larger body size during childhood is 
an indirect sign of a beneficial childhood environment, rather than the early stages of 
obesity. Given that relative weight gain after the age of 11 years was positively 
associated with adult systolic blood pressure, it is furthermore likely that the trajectory 
towards obesity and related conditions began at a later stage for our study participants, 
compared to what has been demonstrated in more contemporary cohorts. This 
conclusion is also supported in studies I and II, where conditional relative weight gain 
after age 11 years was strongly associated with gains in fat mass and body fat 
percentage and the prevalence of NAFLD was highest among those who were small in 
early childhood and subsequently obese as adults. 
 
Both conditional relative weight gain and linear growth between ages 2 and 11 years 
were inversely associated with systolic blood pressure as well as the dichotomous 
hypertension outcome at mean age 66.4 years, despite adjustment for previous systolic 
blood pressure as well as diastolic blood pressure, in the logistic regression analysis. 
No associations, however, were found between conditional growth and the outcome 
variables at the first clinic visit. Accordingly, it would seem that the beneficial effects 
of a more rapid than expected childhood growth in our cohort become increasingly 
apparent with age. 
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6.5 Regional differences in birth size 
 
We analysed differences in birth size between the Åland Islands and Helsinki during 
the years 1937‒44 as a first step in a potential future analysis of early life origins of 
Ålandic health. The Åland Islands have lower prevalence of several NCDs compared 
to the Finnish national mean and additionally one of the highest mean life expectancies 
in the Nordic countries (Terveyden ja hyvinvoinnin laitos (Finnish National Insititute 
for Health and Welfare), 2012, NOMESCO (Nordisk Medicinalstatistisk Komité), 
2011). The average birth weight on the Åland Islands was 3499 grams (SD 508) and 
the average length at birth was 50.4 cm (SD 2.1), 87 grams (95% CI 62; 111) and 0.4 
cm (95% CI 0.3; 0.5) more than in Helsinki, respectively. 
 
The mean weighted estimate of the relative risk for CHD associated with a one kg 
increase of birth weight was reported as 0.83 (95% CI 0.80; 0.86) in a recently 
published meta-analysis (Wang et al., 2014b). The hazard ratio for all-cause mortality 
has been estimated to 0.94 (95% CI 0.92; 0.97) per kg of birth weight (Risnes et al., 
2011). Applying these estimates, the 87 gram difference in birth weight between the 
Åland cohort and the HBCS would only correspond to a very small relative reduction 
in the prevalence of CHD and all-cause mortality. The estimated relative CHD risk and 
relative all-cause mortality hazard ratio would be 0.984 (95% CI 0.980; 0,987) and 
0.995 (95% CI 0.993; 0.997), respectively.  
 
In the 2012 report on regional health differences from the Finnish National Institute for 
Health and Welfare, the Åland Islands were ranked as Finland’s healthiest region. This 
ranking was based on an age-standardized composite index of disease prevalence 
including seven disease categories which are weighed according to influence on 
mortality, health care costs, work disability, and quality of life. A higher score 
represents a higher morbidity and the national mean is set at 100. The Åland Islands 
received a composite score of 68.9 with significantly lower scores for five of seven 
disease categories compared to the national mean. In comparison, the Northern 
Savonia region, in Eastern Finland, received a composite score of 127, the highest in 
the country.  
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An indication that the Ålandic population’s relative healthiness might have early life 
origins can be found in historical records. Anthropometric studies on men born on the 
Åland islands show that the Ålandic population historically have been taller than the 
mainland Finnish population and even among the tallest people worldwide (Arho, 
1934, Sievers, 1927). The Åland population’s mean increase in height between 1768 
and 1968 was 8.4 cm compared to 4.7 cm for Eastern Finns and 6.0 cm for Western 
Finns (Eriksson AW, 1980). A beneficial intrauterine and postnatal environment is 
positively associated with adult height. which in turn is inversely associated with 
cardiovascular and all-cause mortality (Jousilahti et al., 2000). In 2005‒2009, the mean 
life expectancy at birth was 79.7 years for men born on the Åland Islands, 3.2 years 
more than for men born in the rest of Finland. Women born on the Åland Islands had a 
mean life expectancy at birth of 83.1 years, the same as for the rest of the country. In a 
report from 2001‒04, however, the mean life expectancy at birth of Ålandic women 
was 83.9 years, the highest in the Nordic countries.  
 
No causal conclusions can be drawn from the reported difference in birth weight 
between the Åland Islands and Helsinki during the years 1937‒44. However, our 
findings, along with historical records of anthropometric differences between the 
Ålandic population and mainland peers, suggest that a beneficial early life 
environment might have contributed to Ålandic health and longevity, meriting further 
studies.  
  
6.6 Strengths and limitations 
 
General considerations  
 
The Helsinki Birth Cohort Study is a longitudinal study with a large sample-size 
consisting of 13345 individuals born 1934‒44, 2003 of whom have taken part in a 
clinical study which commenced in 2001. 1083 of the study participants attended a 
follow-up at mean age 66.4 years, the most recent clinic visit included in this thesis 
(study IV). Since then, the participants have been followed up on additional occasions. 
Our data set includes detailed records of birth and childhood characteristics as well as 
an extensive collection of data recorded during the clinical study. The 1697 individuals 
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born on the Åland Islands between 1937 and 1944 (study V) represent 44% of all 
births on the islands during these years. 
 
Given the long follow-up time, survivor bias might be a limitation in the HBCS. Only 
individuals who were alive in 1971, when all residents in Finland received a personal 
identification number, were included in the epidemiological study and only those still 
alive in 2001‒04 were included in the clinical study. As a small size at birth is 
associated with premature mortality (Kajantie et al., 2005), the findings of all included 
studies might be attenuated by the fact that the least healthy individuals had already 
died before being eligible for inclusion. 
 
Most of the study participants were either born or grew up during the Second World 
War which might influence the generalizability of our findings. In Helsinki, food 
shortages most likely influenced both maternal and offspring nutritional status. The 
Åland Islands, on the other hand, were mostly unaffected by the war (Rotkirch, 1986).   
 
All HBCS participants were born in Helsinki and additionally attended child welfare 
clinics in the city. Accordingly, they might not be representative of the general 
population of Helsinki or Finland as a whole. However, the socioeconomic status at 
birth of the participants was comparable to the contemporary Helsinki population with 
roughly 60% of the fathers belonging to the labourer category (Salonen et al., 2009c, 
Rosen R, 1962).  
 
Study-specific considerations 
 
In study I, bioelectrical impedance analysis (BIA) was used in the assessment of body 
composition. Previous studies have demonstrated that BIA might underestimate body 
fat percentage, compared to DEXA, when studying men and women from various 
ethnic backgrounds (Gibson et al., 2008). Accordingly, it has been suggested that 
population-specific algorithms should be used when studying individuals of different 
ethnicity (Dehghan and Merchant, 2008, Aleman-Mateo et al., 2010). Given the 
homogenous ethnicity of the participants in the current study, the algorithms supplied 
by the manufacturer were used. It is possible that more precise results might have been 
attained with the use of population-specific algorithms but on the other hand, it is 
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unlikely that this inaccuracy would vary according to birth weight, suggesting that the 
main study findings are unaffected by this potential limitation. Furthermore, BIA is a 
suitable method for large epidemiological studies due to its ease and haste of use, 
compared to DEXA and other alternative methods of measuring body composition. 
 
Studies II and III quantified liver fat content and defined the presence of NAFLD using 
algorithm tests. Although these are associated with a certain degree of diagnostic 
uncertainty, their facility of use make them more suitable for large epidemiological 
studies than more objective methods, e.g. liver biopsy and imaging techniques. 
Another potential limitation in studies II and III is related to the exclusion of 
individuals with daily alcohol intake in excess of 20 g/d based on FFQ data. The 
potential for underreporting of alcohol intake is a well known issue in questionnaires 
and interviews, suggesting that a number of individuals with fatty liver disease 
secondary to alcohol overconsumption might also have been included in the analysis. 
It is unlikely, however, that this would affect the main findings as there is no reason to 
believe that the tendency for underreporting would vary according to childhood growth 
trajectories or fructose intake. 
 
The participants in study IV represent a relatively healthy subsample of the HBCS 
given that only individuals without type 2 diabetes at first clinic study were included in 
the follow-up. This might influence the generalizability of the findings. Furthermore, 
the analyses were based upon blood pressure measurements acquired at the clinic 
visits. As such, they might not fully reflect the participants’ true resting blood pressure. 
On the other hand, there is no reason to believe that the participants’ early growth 
would influence a potential over-estimation of resting blood pressure.   
 
Data on gestational age was missing from the Åland records for all subjects. Without 
this information, it is not possible to determine whether a small size at birth is a result 
of intrauterine growth retardation, short gestation, or a combination of both. 
Furthermore, a majority of the Åland records lacked information on parity. Birth order 
is positively associated with birth weight (Swamy et al., 2012) making it a possible 
confounder for the observed differences in birth weight between the Åland Islands and 
Helsinki. Comparing all in-wedlock births for the years 1942, 1943 and 1943, a larger 
proportion were firstborn in the Uusimaa region (in which Helsinki is located) 
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compared to the Åland Islands, 50‒58% and 32‒39%, respectively (Central Statistical 
Office of Finland, 1946, Central Statistical Office of Finland, 1948, Central Statistical 
Office of Finland, 1943).  
  
6.7 Implications of findings 
 
In our cohort, relative weight gain after age 11 years, i.e. a faster weight gain than 
would have been expected based on previous body size, was associated with increase 
in fat mass, body fat percentage and adult systolic blood pressure. Additionally, the 
prevalence of NAFLD was highest among those who were lean at age 2 years and 
subsequently obese as adults. The participants were relatively lean and short in 
childhood which most likely explains inconsistencies with findings from more 
contemporary longitudinal studies, where growth during earlier periods are also 
associated with detrimental outcomes. Although the findings might not be directly 
applicable on children growing up in Finland and other Western countries today, they 
are still relevant for individuals reaching old age today. Additionally, the findings 
could potentially also be applicable in certain countries in the developing world, 
undergoing socioeconomic and nutritional transitions. 
 
We did not find any support for the hypothesis that fructose intake is associated with 
NAFLD. Instead, those with the highest fructose intake were least likely to suffer from 
fatty liver according to the algorithm scores applied in the study. Given our results, it 
is unclear whether general advice to lower fructose intake would be beneficial without 
also taking the source of fructose into account. 
 
6.8 Potential future studies 
 
We are currently validating the FLI and the NAFLD liver fat score and equation in a 
small subset of women from the HBCS (n = 42) who have undergone MRS, either 
once or twice, as part of a study exploring the influence of maternal obesity on later 
health and frailty. Genome-wide association studies (GWAS) represent another 
attractive field of research. A recent publication from the Raine study identified 
specific short nucleotide polymorphisms (SNPs) associated with the presence of 
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NAFLD (Adams et al., 2013). A similar analysis in the HBCS would be of great 
interest.  
 
Our findings regarding fructose intake and NAFLD merit further study. Our study was 
cross-sectional making it difficult to draw any conclusions in regards to causality. 
Population-based longitudinal studies are needed to further explore these findings. 
 
The findings from study IV indicate that the associations between childhood growth 
and adult blood pressure become more apparent with increasing age. Follow-up studies 
are needed to verify this hypothesis.  
 
Study V showed a small but significant difference in birth size between the Åland 
islands and Helsinki. Register linkage, similar to what has been performed in the 
HBCS, could offer further insight into the potential developmental origins of Ålandic 
health and longevity. 
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7 CONCLUSIONS 
 
1.  The association between birth weight and adult resting metabolic rate 
varies according to sex with an inverse association in women and a 
quadratic in men. Furthermore, we found that relative weight gain after 
age 11 years was strongly associated with body fat mass and percentage, 
whereas linear (height) growth in early childhood and after age 11 years 
was inversely associated with body fat percentage.  
 
2. Individuals who were small at age 2 years and subsequently obese as 
adults were at the highest risk of NAFLD. Conversely, all measurements 
of childhood body size and growth up until age 11 years that achieved 
statistical significance were inversely associated with NAFLD. 
 
3.  Individuals with the highest fructose intake were significantly less likely 
to suffer from NAFLD. This association stayed significant despite 
adjustment for sex, age, smoking, physical activity, and intake of fat, 
alcohol, fiber, and vitamin E.  
  
4.   Relative weight gain and linear growth between ages 2 and 11 years were 
inversely associated with blood pressure at mean age 66.4 years, as well 
as the presence of hypertension for the latter growth measurement, 
despite adjustment for previous blood pressure.  
 
5.   Babies born on the Åland Islands during 1937‒1944 were significantly 
heavier and taller than those born in Helsinki during the same time 
period. 
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